Symbol:
Map3k6
Name:
mitogen-activated protein kinase kinase kinase 6
RGD ID:
1304625
Description:
Predicted to enable ATP binding activity; MAP kinase kinase kinase activity; and magnesium ion binding activity. Predicted to be involved in JNK cascade; p38MAPK cascade; and protein phosphorylation. Orthologous to human MAP3K6 (mitogen-activated protein kinase kinase kinase 6); PARTICIPATES IN p38 MAPK signaling pathway; mitogen activated protein kinase signaling pathway; INTERACTS WITH (+)-schisandrin B; 1-naphthyl isothiocyanate; 2,2',4,4'-Tetrabromodiphenyl ether.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
LOC313022
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
MAP3K6 (mitogen-activated protein kinase kinase kinase 6)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Map3k6 (mitogen-activated protein kinase kinase kinase 6)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Map3k6 (mitogen-activated protein kinase kinase kinase 6)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
MAP3K6 (mitogen-activated protein kinase kinase kinase 6)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
MAP3K6 (mitogen-activated protein kinase kinase kinase 6)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Map3k6 (mitogen-activated protein kinase kinase kinase 6)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
MAP3K6 (mitogen-activated protein kinase kinase kinase 6)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
MAP3K6 (mitogen-activated protein kinase kinase kinase 6)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Map3k6 (mitogen-activated protein kinase kinase kinase 6)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
MAP3K6 (mitogen-activated protein kinase kinase kinase 6)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Map3k6 (mitogen-activated protein kinase kinase kinase 6)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
si:ch211-1i11.3
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER|PhylomeDB)
Drosophila melanogaster (fruit fly):
Ask1
Alliance
DIOPT (Ensembl Compara|InParanoid|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
nsy-1
Alliance
DIOPT (Ensembl Compara|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 150,724,029 - 150,736,113 (+) NCBI GRCr8 mRatBN7.2 5 145,440,126 - 145,452,213 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 145,440,346 - 145,452,212 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 148,143,644 - 148,155,529 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 149,913,247 - 149,925,128 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 149,898,266 - 149,910,136 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 151,435,679 - 151,448,329 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 151,436,464 - 151,448,328 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 155,100,704 - 155,113,502 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 151,873,619 - 151,885,483 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 151,883,659 - 151,908,484 (-) NCBI Celera 5 143,861,707 - 143,873,572 (+) NCBI Celera Cytogenetic Map 5 q36 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Map3k6 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP3K6 mRNA] CTD PMID:31150632 Map3k6 Rat 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of MAP3K6 mRNA CTD PMID:30723492 Map3k6 Rat 17beta-estradiol increases expression ISO Map3k6 (Mus musculus) 6480464 Estradiol results in increased expression of MAP3K6 mRNA CTD PMID:19484750 Map3k6 Rat 17beta-estradiol decreases expression ISO Map3k6 (Mus musculus) 6480464 Estradiol results in decreased expression of MAP3K6 mRNA CTD PMID:39298647 Map3k6 Rat 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO MAP3K6 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of MAP3K6 mRNA CTD PMID:29581250 Map3k6 Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 Map3k6 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Map3k6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP3K6 mRNA CTD PMID:17035482 Map3k6 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO MAP3K6 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP3K6 mRNA CTD PMID:26238291 Map3k6 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Map3k6 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAP3K6 mRNA CTD PMID:25975270 Map3k6 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Map3k6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP3K6 mRNA CTD PMID:21570461 Map3k6 Rat 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of MAP3K6 mRNA CTD PMID:23537331 Map3k6 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of MAP3K6 mRNA CTD PMID:21346803 Map3k6 Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of MAP3K6 mRNA CTD PMID:21346803 Map3k6 Rat 2-palmitoylglycerol increases expression ISO MAP3K6 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of MAP3K6 mRNA CTD PMID:37199045 Map3k6 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO MAP3K6 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP3K6 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K6 mRNA CTD PMID:28628672 Map3k6 Rat 4,4'-sulfonyldiphenol increases methylation ISO Map3k6 (Mus musculus) 6480464 bisphenol S results in increased methylation of MAP3K6 exon and bisphenol S results in increased methylation of MAP3K6 promoter CTD PMID:33297965 Map3k6 Rat 4,4'-sulfonyldiphenol increases expression ISO Map3k6 (Mus musculus) 6480464 bisphenol S results in increased expression of MAP3K6 mRNA CTD PMID:37611474 Map3k6 Rat 4,4'-sulfonyldiphenol affects methylation ISO Map3k6 (Mus musculus) 6480464 bisphenol S affects the methylation of MAP3K6 gene CTD PMID:31683443 Map3k6 Rat 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid decreases expression ISO MAP3K6 (Homo sapiens) 6480464 Am 580 results in decreased expression of MAP3K6 mRNA CTD PMID:16982809 Map3k6 Rat 5-aza-2'-deoxycytidine affects expression ISO MAP3K6 (Homo sapiens) 6480464 Decitabine affects the expression of MAP3K6 mRNA CTD PMID:23300844 Map3k6 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MAP3K6 mRNA CTD PMID:24780913 Map3k6 Rat AB-Fubinaca increases expression EXP 6480464 AB-FUBINACA results in increased expression of MAP3K6 mRNA CTD PMID:26517302 Map3k6 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of MAP3K6 mRNA CTD PMID:31881176 Map3k6 Rat acrolein increases expression EXP 6480464 Acrolein results in increased expression of MAP3K6 mRNA CTD PMID:38090360 Map3k6 Rat acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of MAP3K6 mRNA CTD PMID:28959563 Map3k6 Rat acrylamide decreases expression ISO MAP3K6 (Homo sapiens) 6480464 Acrylamide results in decreased expression of MAP3K6 mRNA CTD PMID:32763439 Map3k6 Rat aflatoxin B1 increases methylation ISO MAP3K6 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of MAP3K6 gene CTD PMID:28458013 Map3k6 Rat all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of MAP3K6 mRNA CTD PMID:20488242 Map3k6 Rat all-trans-retinoic acid decreases expression ISO MAP3K6 (Homo sapiens) 6480464 Tretinoin results in decreased expression of MAP3K6 mRNA CTD PMID:33167477 Map3k6 Rat amosite asbestos decreases methylation ISO MAP3K6 (Homo sapiens) 6480464 Asbestos and Amosite results in decreased methylation of MAP3K6 promoter CTD PMID:29626692 Map3k6 Rat anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO Map3k6 (Mus musculus) 6480464 pyrazolanthrone inhibits the reaction [Ozone results in increased expression of MAP3K6 mRNA] CTD PMID:17460151 Map3k6 Rat antirheumatic drug decreases expression ISO MAP3K6 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of MAP3K6 mRNA CTD PMID:24449571 Map3k6 Rat arsane decreases expression ISO Map3k6 (Mus musculus) 6480464 Arsenic results in decreased expression of MAP3K6 mRNA CTD PMID:19654921 Map3k6 Rat arsenic atom decreases expression ISO Map3k6 (Mus musculus) 6480464 Arsenic results in decreased expression of MAP3K6 mRNA CTD PMID:19654921 Map3k6 Rat arsenous acid increases expression ISO Map3k6 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of MAP3K6 mRNA CTD PMID:35676786 Map3k6 Rat atrazine decreases expression ISO MAP3K6 (Homo sapiens) 6480464 Atrazine results in decreased expression of MAP3K6 mRNA CTD PMID:22378314 Map3k6 Rat benzo[a]pyrene increases expression ISO Map3k6 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of MAP3K6 mRNA CTD PMID:20504355 and PMID:21569818 Map3k6 Rat benzo[a]pyrene affects methylation ISO MAP3K6 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of MAP3K6 promoter CTD PMID:27901495 Map3k6 Rat benzo[a]pyrene increases expression ISO MAP3K6 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of MAP3K6 mRNA CTD PMID:26238291 and PMID:32234424 Map3k6 Rat benzo[a]pyrene decreases expression ISO MAP3K6 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of MAP3K6 protein CTD PMID:32717239 Map3k6 Rat benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of MAP3K6 mRNA CTD PMID:21839799 Map3k6 Rat benzo[a]pyrene diol epoxide I increases expression ISO MAP3K6 (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 Map3k6 Rat benzo[b]fluoranthene increases expression ISO Map3k6 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of MAP3K6 mRNA CTD PMID:26377693 Map3k6 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAP3K6 mRNA CTD PMID:25181051 Map3k6 Rat bisphenol A increases expression ISO Map3k6 (Mus musculus) 6480464 bisphenol A results in increased expression of MAP3K6 mRNA CTD PMID:32156529 Map3k6 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAP3K6 mRNA CTD PMID:32145629 and PMID:34947998 Map3k6 Rat bisphenol A multiple interactions ISO MAP3K6 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP3K6 mRNA CTD PMID:28628672 Map3k6 Rat bisphenol F multiple interactions ISO MAP3K6 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K6 mRNA CTD PMID:28628672 Map3k6 Rat bisphenol F decreases expression ISO Map3k6 (Mus musculus) 6480464 bisphenol F results in decreased expression of MAP3K6 mRNA CTD PMID:38685157 Map3k6 Rat bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of MAP3K6 mRNA CTD PMID:32479839 Map3k6 Rat buta-1,3-diene increases expression ISO Map3k6 (Mus musculus) 6480464 1 and 3-butadiene results in increased expression of MAP3K6 mRNA CTD PMID:29038090 Map3k6 Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of MAP3K6 mRNA CTD PMID:19167457 Map3k6 Rat cadmium atom increases expression ISO MAP3K6 (Homo sapiens) 6480464 Cadmium results in increased expression of MAP3K6 mRNA CTD PMID:22562489 Map3k6 Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of MAP3K6 mRNA CTD PMID:33453195 Map3k6 Rat cadmium dichloride increases expression ISO MAP3K6 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of MAP3K6 mRNA CTD PMID:38382870 Map3k6 Rat calciol decreases expression ISO Map3k6 (Mus musculus) 6480464 Cholecalciferol results in decreased expression of MAP3K6 mRNA CTD PMID:16508948 Map3k6 Rat cannabidiol increases expression ISO Map3k6 (Mus musculus) 6480464 Cannabidiol results in increased expression of MAP3K6 mRNA CTD PMID:31052254 Map3k6 Rat carbon nanotube affects expression ISO Map3k6 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Map3k6 Rat carbon nanotube increases expression ISO Map3k6 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 Map3k6 Rat chloroprene increases expression ISO Map3k6 (Mus musculus) 6480464 Chloroprene results in increased expression of MAP3K6 mRNA CTD PMID:23125180 Map3k6 Rat choline multiple interactions ISO Map3k6 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP3K6 mRNA CTD PMID:20938992 Map3k6 Rat chromium(6+) affects expression ISO Map3k6 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of MAP3K6 mRNA CTD PMID:28472532 Map3k6 Rat ciguatoxin CTX1B affects expression ISO Map3k6 (Mus musculus) 6480464 Ciguatoxins affects the expression of MAP3K6 mRNA CTD PMID:18353800 Map3k6 Rat cisplatin affects expression ISO MAP3K6 (Homo sapiens) 6480464 Cisplatin affects the expression of MAP3K6 mRNA CTD PMID:23300844 Map3k6 Rat cisplatin multiple interactions ISO MAP3K6 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of MAP3K6 mRNA CTD PMID:27392435 Map3k6 Rat cisplatin multiple interactions ISO Map3k6 (Mus musculus) 6480464 [Cisplatin co-treated with RELB mutant form] results in decreased expression of MAP3K6 mRNA CTD PMID:23625948 Map3k6 Rat copper atom multiple interactions ISO MAP3K6 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MAP3K6 mRNA CTD PMID:30911355 Map3k6 Rat copper(0) multiple interactions ISO MAP3K6 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MAP3K6 mRNA CTD PMID:30911355 Map3k6 Rat crocidolite asbestos affects expression ISO MAP3K6 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of MAP3K6 mRNA CTD PMID:17331233 Map3k6 Rat crocidolite asbestos decreases methylation ISO MAP3K6 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased methylation of MAP3K6 promoter CTD PMID:29626692 Map3k6 Rat dexamethasone increases expression ISO Map3k6 (Mus musculus) 6480464 Dexamethasone results in increased expression of MAP3K6 mRNA CTD PMID:22733784 Map3k6 Rat dexamethasone multiple interactions ISO MAP3K6 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP3K6 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K6 mRNA CTD PMID:28628672 Map3k6 Rat diarsenic trioxide increases expression ISO Map3k6 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of MAP3K6 mRNA CTD PMID:35676786 Map3k6 Rat diazinon affects expression EXP 6480464 Diazinon affects the expression of MAP3K6 mRNA CTD PMID:22546817 Map3k6 Rat dibenz[a,h]anthracene increases expression ISO Map3k6 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 Map3k6 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of MAP3K6 mRNA CTD PMID:21266533 Map3k6 Rat dieldrin affects expression EXP 6480464 Dieldrin affects the expression of MAP3K6 mRNA CTD PMID:22546817 Map3k6 Rat dimethylarsinic acid decreases expression ISO Map3k6 (Mus musculus) 6480464 Cacodylic Acid results in decreased expression of MAP3K6 mRNA CTD PMID:17441966 Map3k6 Rat dioxygen multiple interactions ISO Map3k6 (Mus musculus) 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of MAP3K6 mRNA CTD PMID:30529165 Map3k6 Rat dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MAP3K6 mRNA CTD PMID:33729688 Map3k6 Rat diquat increases expression ISO Map3k6 (Mus musculus) 6480464 Diquat results in increased expression of MAP3K6 mRNA CTD PMID:36851058 Map3k6 Rat doxorubicin increases expression ISO Map3k6 (Mus musculus) 6480464 Doxorubicin results in increased expression of MAP3K6 mRNA CTD PMID:21040762 Map3k6 Rat doxorubicin multiple interactions ISO Map3k6 (Mus musculus) 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of MAP3K6 mRNA CTD PMID:21040762 Map3k6 Rat doxycycline multiple interactions ISO Map3k6 (Mus musculus) 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MAP3K6 mRNA] CTD PMID:18089841 Map3k6 Rat entinostat increases expression ISO MAP3K6 (Homo sapiens) 6480464 entinostat results in increased expression of MAP3K6 mRNA CTD PMID:27188386 Map3k6 Rat ethanol affects expression ISO Map3k6 (Mus musculus) 6480464 Ethanol affects the expression of MAP3K6 mRNA CTD PMID:30319688 Map3k6 Rat fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of MAP3K6 mRNA CTD PMID:30307764 Map3k6 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of MAP3K6 mRNA CTD PMID:24793618 Map3k6 Rat folic acid multiple interactions ISO Map3k6 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP3K6 mRNA CTD PMID:20938992 Map3k6 Rat furan increases expression EXP 6480464 furan results in increased expression of MAP3K6 mRNA CTD PMID:25539665 and PMID:26194646 Map3k6 Rat gallic acid increases expression ISO MAP3K6 (Homo sapiens) 6480464 Gallic Acid results in increased expression of MAP3K6 mRNA CTD PMID:34408198 Map3k6 Rat genistein increases expression ISO Map3k6 (Mus musculus) 6480464 Genistein results in increased expression of MAP3K6 mRNA CTD PMID:24967385 Map3k6 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MAP3K6 mRNA CTD PMID:33387578 Map3k6 Rat graphene oxide increases expression ISO Map3k6 (Mus musculus) 6480464 graphene oxide results in increased expression of MAP3K6 mRNA CTD PMID:33227293 Map3k6 Rat hydrogen sulfide increases expression ISO Map3k6 (Mus musculus) 6480464 Hydrogen Sulfide results in increased expression of MAP3K6 mRNA CTD PMID:31843631 Map3k6 Rat indometacin multiple interactions ISO MAP3K6 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP3K6 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K6 mRNA CTD PMID:28628672 Map3k6 Rat irinotecan increases expression EXP 6480464 Irinotecan results in increased expression of MAP3K6 mRNA CTD PMID:20097248 Map3k6 Rat isoprenaline multiple interactions ISO Map3k6 (Mus musculus) 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MAP3K6 mRNA] CTD PMID:18089841 Map3k6 Rat isoprenaline increases expression ISO Map3k6 (Mus musculus) 6480464 Isoproterenol results in increased expression of MAP3K6 mRNA CTD PMID:18089841 and PMID:20003209 Map3k6 Rat L-methionine multiple interactions ISO Map3k6 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP3K6 mRNA CTD PMID:20938992 Map3k6 Rat mancozeb increases expression ISO Map3k6 (Mus musculus) 6480464 mancozeb results in increased expression of MAP3K6 mRNA CTD PMID:36007320 Map3k6 Rat methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of MAP3K6 mRNA CTD PMID:28935588 Map3k6 Rat methotrexate affects expression ISO Map3k6 (Mus musculus) 6480464 Methotrexate affects the expression of MAP3K6 mRNA CTD PMID:18502557 Map3k6 Rat methotrexate decreases expression ISO MAP3K6 (Homo sapiens) 6480464 Methotrexate results in decreased expression of MAP3K6 mRNA CTD PMID:24449571 Map3k6 Rat N-methyl-4-phenylpyridinium decreases expression ISO MAP3K6 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MAP3K6 mRNA CTD PMID:25234470 Map3k6 Rat N-nitrosodiethylamine multiple interactions ISO Map3k6 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of MAP3K6 mRNA CTD PMID:26778414 Map3k6 Rat naphthalene increases expression ISO Map3k6 (Mus musculus) 6480464 naphthalene results in increased expression of MAP3K6 mRNA CTD PMID:18978301 Map3k6 Rat Nor-9-carboxy-delta9-THC multiple interactions ISO MAP3K6 (Homo sapiens) 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MAP3K6 gene CTD PMID:30521419 Map3k6 Rat ozone multiple interactions ISO Map3k6 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAP3K6 mRNA more ... CTD PMID:17460151 more ... Map3k6 Rat ozone increases expression ISO Map3k6 (Mus musculus) 6480464 Ozone results in increased expression of MAP3K6 mRNA CTD PMID:17095637 and PMID:19555225 Map3k6 Rat paracetamol affects expression ISO Map3k6 (Mus musculus) 6480464 Acetaminophen affects the expression of MAP3K6 mRNA CTD PMID:17562736 Map3k6 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MAP3K6 mRNA CTD PMID:32479839 and PMID:33387578 Map3k6 Rat paracetamol increases expression ISO Map3k6 (Mus musculus) 6480464 Acetaminophen results in increased expression of MAP3K6 mRNA CTD PMID:19420014 Map3k6 Rat paraquat increases expression ISO Map3k6 (Mus musculus) 6480464 Paraquat results in increased expression of MAP3K6 mRNA CTD PMID:12595580 and PMID:21463325 Map3k6 Rat phenobarbital affects expression ISO MAP3K6 (Homo sapiens) 6480464 Phenobarbital affects the expression of MAP3K6 mRNA CTD PMID:19159669 Map3k6 Rat pirinixic acid increases expression ISO Map3k6 (Mus musculus) 6480464 pirinixic acid results in increased expression of MAP3K6 mRNA CTD PMID:18445702 Map3k6 Rat pregnenolone 16alpha-carbonitrile increases expression ISO Map3k6 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of MAP3K6 mRNA CTD PMID:28903501 Map3k6 Rat serpentine asbestos decreases methylation ISO MAP3K6 (Homo sapiens) 6480464 Asbestos and Serpentine results in decreased methylation of MAP3K6 promoter CTD PMID:29626692 Map3k6 Rat sodium arsenite increases expression ISO MAP3K6 (Homo sapiens) 6480464 sodium arsenite results in increased expression of MAP3K6 mRNA CTD PMID:34032870 Map3k6 Rat sulforaphane multiple interactions ISO Map3k6 (Mus musculus) 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of MAP3K6 mRNA CTD PMID:30529165 Map3k6 Rat sulforaphane decreases expression ISO Map3k6 (Mus musculus) 6480464 sulforaphane results in decreased expression of MAP3K6 mRNA CTD PMID:30529165 Map3k6 Rat tert-butyl hydroperoxide decreases expression ISO MAP3K6 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of MAP3K6 mRNA CTD PMID:15336504 Map3k6 Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MAP3K6 mRNA CTD PMID:31150632 Map3k6 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP3K6 mRNA] CTD PMID:31150632 Map3k6 Rat tetrachloromethane increases expression ISO Map3k6 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of MAP3K6 mRNA CTD PMID:27339419 and PMID:31919559 Map3k6 Rat tetrachloromethane multiple interactions ISO Map3k6 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of MAP3K6 mRNA CTD PMID:26778414 Map3k6 Rat thimerosal decreases expression ISO MAP3K6 (Homo sapiens) 6480464 Thimerosal results in decreased expression of MAP3K6 mRNA CTD PMID:27188386 Map3k6 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MAP3K6 mRNA CTD PMID:23411599 and PMID:34492290 Map3k6 Rat thiram decreases expression ISO MAP3K6 (Homo sapiens) 6480464 Thiram results in decreased expression of MAP3K6 mRNA CTD PMID:38568856 Map3k6 Rat titanium dioxide increases expression ISO Map3k6 (Mus musculus) 6480464 titanium dioxide results in increased expression of MAP3K6 mRNA CTD PMID:27760801 Map3k6 Rat titanium dioxide increases methylation ISO Map3k6 (Mus musculus) 6480464 titanium dioxide results in increased methylation of MAP3K6 gene CTD PMID:35295148 Map3k6 Rat titanium dioxide decreases expression ISO Map3k6 (Mus musculus) 6480464 titanium dioxide results in decreased expression of MAP3K6 mRNA CTD PMID:19464567 and PMID:23557971 Map3k6 Rat tributylstannane decreases expression ISO Map3k6 (Mus musculus) 6480464 tributyltin results in decreased expression of MAP3K6 mRNA CTD PMID:31939706 Map3k6 Rat trichostatin A increases expression ISO MAP3K6 (Homo sapiens) 6480464 trichostatin A results in increased expression of MAP3K6 mRNA CTD PMID:24935251 Map3k6 Rat triclosan increases expression ISO MAP3K6 (Homo sapiens) 6480464 Triclosan results in increased expression of MAP3K6 mRNA CTD PMID:30510588 Map3k6 Rat trimellitic anhydride decreases expression ISO Map3k6 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of MAP3K6 mRNA CTD PMID:19042947 Map3k6 Rat triphenyl phosphate affects expression ISO MAP3K6 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of MAP3K6 mRNA CTD PMID:37042841 Map3k6 Rat urethane increases expression ISO MAP3K6 (Homo sapiens) 6480464 Urethane results in increased expression of MAP3K6 mRNA CTD PMID:28818685 Map3k6 Rat valproic acid increases expression ISO Map3k6 (Mus musculus) 6480464 Valproic Acid results in increased expression of MAP3K6 mRNA CTD PMID:21427059 Map3k6 Rat valproic acid increases methylation ISO MAP3K6 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of MAP3K6 gene CTD PMID:29154799
Imported Annotations - KEGG (archival)
Imported Annotations - PID (archival)
(+)-schisandrin B (EXP) 1-naphthyl isothiocyanate (EXP) 17beta-estradiol (ISO) 17beta-hydroxy-5alpha-androstan-3-one (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (EXP) 2,3,7,8-tetrachlorodibenzodioxine (ISO) 2,4,6-trinitrobenzenesulfonic acid (EXP) 2,4-dinitrotoluene (EXP) 2,6-dinitrotoluene (EXP) 2-palmitoylglycerol (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (ISO) 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid (ISO) 5-aza-2'-deoxycytidine (ISO) 6-propyl-2-thiouracil (EXP) AB-Fubinaca (EXP) acetamide (EXP) acrolein (EXP) acrylamide (EXP,ISO) aflatoxin B1 (ISO) all-trans-retinoic acid (EXP,ISO) amosite asbestos (ISO) anthra[1,9-cd]pyrazol-6(2H)-one (ISO) antirheumatic drug (ISO) arsane (ISO) arsenic atom (ISO) arsenous acid (ISO) atrazine (ISO) benzo[a]pyrene (EXP,ISO) benzo[a]pyrene diol epoxide I (ISO) benzo[b]fluoranthene (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) bromobenzene (EXP) buta-1,3-diene (ISO) C60 fullerene (EXP) cadmium atom (ISO) cadmium dichloride (EXP,ISO) calciol (ISO) cannabidiol (ISO) carbon nanotube (ISO) chloroprene (ISO) choline (ISO) chromium(6+) (ISO) ciguatoxin CTX1B (ISO) cisplatin (ISO) copper atom (ISO) copper(0) (ISO) crocidolite asbestos (ISO) dexamethasone (ISO) diarsenic trioxide (ISO) diazinon (EXP) dibenz[a,h]anthracene (ISO) dibutyl phthalate (EXP) dieldrin (EXP) dimethylarsinic acid (ISO) dioxygen (EXP,ISO) diquat (ISO) doxorubicin (ISO) doxycycline (ISO) entinostat (ISO) ethanol (ISO) fenvalerate (EXP) flutamide (EXP) folic acid (ISO) furan (EXP) gallic acid (ISO) genistein (ISO) gentamycin (EXP) graphene oxide (ISO) hydrogen sulfide (ISO) indometacin (ISO) irinotecan (EXP) isoprenaline (ISO) L-methionine (ISO) mancozeb (ISO) methapyrilene (EXP) methotrexate (ISO) N-methyl-4-phenylpyridinium (ISO) N-nitrosodiethylamine (ISO) naphthalene (ISO) Nor-9-carboxy-delta9-THC (ISO) ozone (ISO) paracetamol (EXP,ISO) paraquat (ISO) phenobarbital (ISO) pirinixic acid (ISO) pregnenolone 16alpha-carbonitrile (ISO) serpentine asbestos (ISO) sodium arsenite (ISO) sulforaphane (ISO) tert-butyl hydroperoxide (ISO) tetrachloromethane (EXP,ISO) thimerosal (ISO) thioacetamide (EXP) thiram (ISO) titanium dioxide (ISO) tributylstannane (ISO) trichostatin A (ISO) triclosan (ISO) trimellitic anhydride (ISO) triphenyl phosphate (ISO) urethane (ISO) valproic acid (ISO)
Map3k6 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 150,724,029 - 150,736,113 (+) NCBI GRCr8 mRatBN7.2 5 145,440,126 - 145,452,213 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 145,440,346 - 145,452,212 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 148,143,644 - 148,155,529 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 149,913,247 - 149,925,128 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 149,898,266 - 149,910,136 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 151,435,679 - 151,448,329 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 151,436,464 - 151,448,328 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 155,100,704 - 155,113,502 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 151,873,619 - 151,885,483 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 151,883,659 - 151,908,484 (-) NCBI Celera 5 143,861,707 - 143,873,572 (+) NCBI Celera Cytogenetic Map 5 q36 NCBI
MAP3K6 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 27,355,184 - 27,366,961 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 27,355,184 - 27,366,961 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 27,681,675 - 27,693,452 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 27,554,257 - 27,565,924 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 27,365,811 - 27,377,479 NCBI Celera 1 26,078,953 - 26,090,620 (-) NCBI Celera Cytogenetic Map 1 p36.11 NCBI HuRef 1 25,937,810 - 25,949,477 (-) NCBI HuRef CHM1_1 1 27,796,403 - 27,808,071 (-) NCBI CHM1_1 T2T-CHM13v2.0 1 27,196,422 - 27,208,199 (-) NCBI T2T-CHM13v2.0
Map3k6 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 4 132,965,290 - 132,980,240 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 4 132,968,129 - 132,980,240 (+) Ensembl GRCm39 Ensembl GRCm38 4 133,237,979 - 133,252,929 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 4 133,240,818 - 133,252,929 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 4 132,796,733 - 132,808,843 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 4 132,512,894 - 132,525,004 (+) NCBI MGSCv36 mm8 Celera 4 131,406,471 - 131,418,534 (+) NCBI Celera Cytogenetic Map 4 D2.3 NCBI cM Map 4 66.25 NCBI
Map3k6 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955452 6,616,997 - 6,629,206 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955452 6,616,997 - 6,628,745 (-) NCBI ChiLan1.0 ChiLan1.0
MAP3K6 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 199,511,898 - 199,525,275 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 198,617,568 - 198,629,253 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 26,607,436 - 26,619,463 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 27,663,250 - 27,674,240 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 27,662,777 - 27,673,987 (-) Ensembl panpan1.1 panPan2
MAP3K6 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 2 72,904,611 - 72,916,280 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 2 72,905,244 - 72,917,057 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 2 69,481,563 - 69,494,283 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 2 73,465,488 - 73,478,984 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 2 73,466,663 - 73,478,356 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 2 70,291,490 - 70,304,986 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 2 71,303,724 - 71,315,393 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 2 72,299,020 - 72,312,519 (+) NCBI UU_Cfam_GSD_1.0
Map3k6 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405058 45,842,814 - 45,854,132 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936474 11,664,725 - 11,679,507 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936474 11,667,482 - 11,680,042 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
MAP3K6 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 6 84,573,329 - 84,585,392 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 6 84,573,327 - 84,585,428 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 6 78,144,525 - 78,156,627 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
MAP3K6 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 20 105,421,677 - 105,433,902 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 20 105,421,829 - 105,433,970 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666033 11,024,967 - 11,036,597 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Map3k6 (Heterocephalus glaber - naked mole-rat)
.
Assembly: RGSC_v3.4
Assembly: Rnor_5.0
Assembly: Rnor_6.0
Predicted Target Of
Count of predictions: 100 Count of miRNA genes: 84 Interacting mature miRNAs: 87 Transcripts: ENSRNOT00000012463 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1331796 Thshl2 Thyroid stimulating hormone level QTL 2 2.3 blood thyroid-stimulating hormone amount (VT:0005119) serum thyroid stimulating hormone level (CMO:0001248) 5 97059760 147465714 Rat 10053720 Scort26 Serum corticosterone level QTL 26 2.06 0.0147 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 5 124965598 166875058 Rat 1549845 Scl44 Serum cholesterol level QTL 44 6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 40128307 148607290 Rat 8552960 Pigfal15 Plasma insulin-like growth factor 1 level QTL 15 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 111416838 156416838 Rat 2302369 Scl60 Serum cholesterol level QTL 60 3.13 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 143608201 161165651 Rat 631562 Apr2 Acute phase response QTL 2 3.7 blood murinoglobulin 1 amount (VT:0010597) plasma murinoglobulin 1 level (CMO:0001931) 5 135927956 166875058 Rat 61444 Strs2 Sensitivity to stroke QTL 2 4.7 cerebrum integrity trait (VT:0010549) post-insult time to onset of cerebrovascular lesion (CMO:0002343) 5 135929696 166875058 Rat 1300119 Bp180 Blood pressure QTL 180 3.82 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 5 144358090 157869054 Rat 70156 Niddm30 Non-insulin dependent diabetes mellitus QTL 30 3.98 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 5 129132447 151006154 Rat 8552908 Pigfal4 Plasma insulin-like growth factor 1 level QTL 4 6.6 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 128506074 166875058 Rat 61393 Bp7 Blood pressure QTL 7 4.5 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 60293434 161481680 Rat 7794791 Mcs33 Mammary carcinoma susceptibility QTL 33 1.93 mammary gland integrity trait (VT:0010552) mammary tumor incidence/prevalence measurement (CMO:0000946) 5 131345754 166875058 Rat 7207486 Bss109 Bone structure and strength QTL 109 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 5 106906205 151906205 Rat 7207481 Bss106 Bone structure and strength QTL 106 7.9 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 5 106906205 151906205 Rat 1302790 Scl20 Serum cholesterol level QTL 20 6.4 0.0001 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 82394392 166664054 Rat 1598861 Cm64 Cardiac mass QTL 64 2.9 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 127798274 166875058 Rat 1578766 Tcas11 Tongue tumor susceptibility QTL 11 4.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 5 46711509 161317411 Rat 631263 Cm24 Cardiac mass QTL 24 3.5 heart mass (VT:0007028) heart left ventricle weight to body weight ratio (CMO:0000530) 5 143799107 158428037 Rat 631505 Bp103 Blood pressure QTL 103 3.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 132717196 165560427 Rat 1549838 Bss4 Bone structure and strength QTL 4 9.2 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 5 106906205 151906205 Rat 1641920 Colcs1 Colorectal carcinoma susceptibility QTL 1 2.99 0.0055 intestine integrity trait (VT:0010554) benign colorectal tumor surface area measurement (CMO:0001799) 5 121846814 166846814 Rat 8694169 Bw148 Body weight QTL 148 5 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 128506074 166875058 Rat 1331721 Bp210 Blood pressure QTL 210 3.413 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 5 143069996 166846814 Rat 8657050 Bw146 Body weight QTL 146 19.84 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 108938288 153938288 Rat 1576314 Eutr1 Estrogen induced uterine response QTL 1 uterus integrity trait (VT:0010575) pyometritis severity score (CMO:0002009) 5 2138965 166875058 Rat 2317056 Wbc3 White blood cell count QTL 3 2.51 0.01 leukocyte quantity (VT:0000217) white blood cell count (CMO:0000027) 5 105999803 150999803 Rat 634349 Bp139 Blood pressure QTL 139 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 128924607 166875058 Rat 724525 Bp147 Blood pressure QTL 147 4.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 126424772 166875058 Rat 1598847 Cm62 Cardiac mass QTL 62 3.4 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 108845856 153845856 Rat 2293642 Bss37 Bone structure and strength QTL 37 4.64 0.0001 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 5 120740824 151018848 Rat 1578673 Bmd13 Bone mineral density QTL 13 4.9 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 5 103689353 148689353 Rat 738018 Anxrr4 Anxiety related response QTL 4 5.1 exploratory behavior trait (VT:0010471) percentage of entries into a discrete space in an experimental apparatus (CMO:0000961) 5 130130159 166875058 Rat 2313096 Bmd78 Bone mineral density QTL 78 3.1 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 5 144377876 161317411 Rat 7207488 Bss110 Bone structure and strength QTL 1 8.4 femur strength trait (VT:0010010) femur stiffness (CMO:0001674) 5 106906205 151906205 Rat 8694441 Bw169 Body weight QTL 169 17.61 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 5 111416838 156416838 Rat 7207491 Bss112 Bone structure and strength QTL 112 7 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 5 106906205 151906205 Rat 8694389 Bw160 Body weight QTL 160 6.17 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 5 111416838 156416838 Rat 1354598 Srn6 Serum renin concentration QTL 6 3.8 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 5 69540295 151018848 Rat 8694198 Abfw3 Abdominal fat weight QTL 3 16.13 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 5 111416838 156416838 Rat 1298089 Scl14 Serum cholesterol level QTL 14 5.8 0.0004 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 108845856 153845856 Rat 1598819 Bp292 Blood pressure QTL 292 4.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 127798274 166875058 Rat 1358187 Emca1 Estrogen-induced mammary cancer QTL 1 4.4 mammary gland integrity trait (VT:0010552) post-insult time to mammary tumor formation (CMO:0000345) 5 99216724 148607142 Rat
RH130321
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 5 145,451,946 - 145,452,157 (+) MAPPER mRatBN7.2 Rnor_6.0 5 151,448,063 - 151,448,273 NCBI Rnor6.0 Rnor_5.0 5 155,113,236 - 155,113,446 UniSTS Rnor5.0 RGSC_v3.4 5 151,873,674 - 151,873,884 UniSTS RGSC3.4 Celera 5 143,873,307 - 143,873,517 UniSTS RH 3.4 Map 5 977.8 UniSTS Cytogenetic Map 5 q36 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000012463 ⟹ ENSRNOP00000012463
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 145,440,346 - 145,452,212 (+) Ensembl Rnor_6.0 Ensembl 5 151,436,464 - 151,448,328 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000093926 ⟹ ENSRNOP00000080621
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 145,440,346 - 145,452,212 (+) Ensembl
RefSeq Acc Id:
NM_001107909 ⟹ NP_001101379
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 150,724,245 - 150,736,113 (+) NCBI mRatBN7.2 5 145,440,346 - 145,452,212 (+) NCBI Rnor_6.0 5 151,436,464 - 151,448,328 (+) NCBI Rnor_5.0 5 155,100,704 - 155,113,502 (+) NCBI RGSC_v3.4 5 151,873,619 - 151,885,483 (-) RGD Celera 5 143,861,707 - 143,873,572 (+) RGD
Sequence:
TCAGGGTGTAGCACGCTGCCGGTTGAATTCCCAGGATCCTTCTGTGACCTGTGAGCCGAGGATTACTGGGTACCCCAGATTCCCAGAACCCAGTCCTGGATTGCAGATCTCTAAGGACCGTGAAAGAT TAAGCAAAGATTTCTCTCTGGATTTAAGATTTCCGGAACAGGACGTCCAGCCCATCTCCGGATCCCGGCTGGATCCACACCTTCAGCCTCGTGCCCTGTCCCGGGTCTCCCGCGCCCGGCGTCCCGCG CTTGAGCGCCCCCGCATGGCGGGGCCGTGTCCCGGGGCCGGGGTTCTAGAACGGGCGGGCAGCTGCTGGCAGGACCCTCTGGCGGAGGCGCTGAGCCGGGGCCGCTCGTCTCCTGCGGTCGCCGGTCG GGGCTGCGCGCGGAGCCGGCCTCTCAGTGTGGTCTACGTGTTGACCCGCGAGCCTGGACCCGGGGTGGAGCCCGGGTCGGGAACCGAGGCAGAGCCGCTGCCGCTGCGATGCCTGCGCGAGGCCTGTG CTCAGCTCCAGAGCACGCGGCCACCCCCGCAACTGCGCAGCCTGCCCTTTGCGACGCTGGCGCTAGGCGACACCGCTGCGCTAGACTCCTTCTACAACGCGGACGTAGTGGTGCTGGAGGTGAGCAAC TCCCTGGCACAGCCTTCCTTGTTCTACCACCTCGGCGTGCGTGAGAGCTTCAGCATGACCAACAATGTGCTCCTCTGTTCCCAGGCAGAGCTCCCTGACCTGCAGGCCCTTCGTGAGGATGTTTTCCA GAAGAACTCGGATTGCGTTGGCAGCTACACACTGATTCCTTATGTTGTGACAGCCACTGGCCGGGTCTTATGTGGCGATGCAGGCCTCCTGAGGGGCATAGCCGATGGGCTAGTACAGGCTGGGGTGG GCACTGAGGCCCTCCTCACGCCCCTGGTGGGCCGGCTTGTCCGTCTCTTGGAGGCCACACCCACAGACTCTTGCGGCTACTTCCGGGAGACCATTCGTCAAGATATCCGGAAGGCACGGGAGCGGTTC AGCGGGCAGCAGCTGAGGCAGGAGCTGGCTCGCCTGCAGCGGAGGCTGGACAGCGTAGAGCTGTTGAGCCCCGACATCATCATGAATCTGCTTCTGTCATACCGCGACGTCCAGGACTACTCCGCCAT CATTGAGCTGGTGGAGACGCTGCAGGCTTTGCCCACCTGTGATGTGGCCGAACAGCACAATGTCTGCTTCCACTACACGTTTGCCCTCAACAGGAGGAACAGGCCTGGGGACCGTGAGAAGGCCCTGG CTGTCCTTCTGCCATTGGTGAAGCATGAAGGCCCCGTGGCTCCAGACCTGTACTGCATGTGTGGTCGTATCTACAAGGACATGTTCTTCAGCTCCAGCTTCCAAAGTACTGGGCACCTGGAGCAGGCC TATCACTGGTACCGCAAGGCATTTGATGTGGAGCCCAGCCTACACTCGGGCATCAATGCAGCTGTGCTGCTCATTGCAGCTGGGAAACACTTTGACGACTCTGAGGAGCTCCAGCTGATAGGCATGAA GCTGGGCTGCCTGTTAGCCCGCAAAGGCTGTGTGGAGAAGATGCAGTATTACTGGGACGTGGGGTTCTACCTGGGAGCCCAGATTCTTGCCAACGACCCCATCCAGGTGGTGCTGGCTGCAGAACAAC TATACAAGCTCAATGCCCCCATATGGTACTTGGTGTCAGTGATGGAGACCTTCTTACTGTACCAGCATTTCAGACCCACACCAGAGCCCTCGGGAGGACCCGTGCTGCGAGCTCACTTTTGGCTCCAT TTCTTGCTACAATCCTGCCAGCCTTTCAAGGCGACCCCTCCTCAGGAGGACCAGTGCCTGGTACTGGTGCTGGAGATAAACAAGGTTCTGCTGCCTGCCAGACTTGAGATTCAGGGAGCCGACCCCAT GAGCGCAGTGACCCTAAGCTTGCTGGAGCCAGAGACTCAGGATGATCCTTCCAGCTGGACCTTCCCAGTCACCTCCATCTGTGGGATCAGCGCCTCCAAGCTGGACCAGCGCTGCTGCTTCCTGTACG CACTTCCTCCGGCCCAGGACGTCCAGCTGTGCTTTCCCAGCGTAGAGCGCTGCCGGTGGTTCTGTAGCCAAATTCAGGTCTTGGTGATGAATCCAGATTCCTCGGCGCCCACTGAGGAGGCAGAAGGC ACAAGGGAGGTGCTGGAGTTTGATTATGAATATTCGGAGACGGGTGAGCGGCTGGTGCTGGGCAAAGGCACGTACGGGGTGGTGTATGCTGGCCGCGACAGGCACACGAGGGTACGAATCGCCATCAA AGAGATCCCAGAGAGAGATAGCAGATTCTCTCAGCCTCTGCACGAGGAGATCGCTCTCCACAAACGCCTTCGCCACAAGAATATAGTGCGCTATTTGGGCTCAGCCAGCCAGGGCGGCTACCTCAAGA TCTTCATGGAGGAAGTGCCTGGAGGCAGCCTGTCCTCCTTGCTTAGGTCAGTGTGGGGACCCCTAAAGGACAACGAGAGTACTATTAGCTTCTACACGCGTCAGATCCTGCAAGGACTTAGCTACCTG CATGAGAACCGCATTGTTCACCGAGACATCAAGGGGGACAATGTACTGATCAACACCTTCAGTGGGCTGCTCAAGATTTCTGACTTTGGCACCTCCAAGCGGCTGGCAGGCATCACACCCTGCACGGA GACTTTCACAGGGACCCTGCAGTATATGGCCCCAGAAATCATTGACCAGGGCCCACGAGGATATGGAAAGGCGGCTGACATCTGGTCTCTGGGCTGCACTGTGATTGAGATGGCCACAGGTTGGCCGC CCTTTCACGAACTAGGGAGCCCGCAGGCTGCCATGTTTCAGGTGGGCATGTACAAGGTACATCCACCAGTGCCAAGTTCCCTGTCAGCTGAGGCCCAAGCCTTCCTCCTCCGAACTTTTGAGCCAGAT CCCCGCCTCCGAGCCAGTGCCCAAGAGCTGTTGGGAGACCCCTTCCTGCAACCAGGGAAGAGGAGCCGCAGCCCTGGCTCTCCTCGGCACACTCCCCGGCCCTCAGGCACCCCTTCCAGTACTTCCAG TCCTTCAGCTGACTCAGCCACACAGTCTCAGACATTCCCAAGGCCCCAGGCACCCTCTCAGCACCCACCCAGCCCTCCGAAGCGCTGCCTTAGTTATGGGGACACCAGTCAGCTCCGTGTGCCCGAGG AATCCGCTGCCGAGGAACCCGCGTCCCCAGAAGAGAGTTCAGGCCTGAGCCTGCTGCACCAGGAGAGCAAGCGCCGAGCCATGCTGGCTGCAGTGCTGGAACAGGAGGTGCCCATACTAGCAGAGAAT CTCCTGGATCAGGAACAGGATTCTCGACTCAGCAGGAATCATGTGGAACTTCTGCTTCGGTGCCTCGGGGCACAAATCCATACTCCTAACCGCCGGCAGCTGGCCCAGGAGCTGCGGGCCCTGCAAGC TCAACTGCGGGCCCAGAGCCTGAGCCCTGCGCTTTTGAAGGGGCCGCTCTTCGCCTTTCCAGACGCGGTGAAGCAGATCCTCCGCAGACGCCAGATCCGCCCACACTGGATGTTCGTGTTGGACTCGC TGCTCAGCCGGGCAGTCCGGGCGGCGCTGGCCGTACTGGACGCGGAGGCAGAGAAGAAAGCGGTCTCACCGAAGTCAGAGGAGTGGAGTCAAGGGGAGTCCCAGCAGAAACCGCTGGAGAGCCAGCCG CCGCTGCAGAGTCAGCTCCCACCAGAGCAGGAACCTCCATCCCTGATGATACAGCTGGGTCTCTTGCGAGCTGAGACTGACAGGCTTCGGGACATTCTGGCTGAGAAGGAACGTGAGTGCCAGGCCCT CGTGCAACAGGCCCTGCATCGGGTGCACGCAGAGACCAGGACGTATGCCCTGGCTTCAGAGACCCCGGCCACTCTCCCAAAGGACCAGAAACTGGTGCAGTGGCTACAGGACCTGAGTGTAGATCCAA CCACTATCCAAACGCTCCTGAGCCATAGCTTTACCCTTCAAACCCTGCTCACCTGTGCCACTCAGGATGACCTCGTCTACACCAGAATCAGGGGAGGGATGGTATGCAGAATTTGGAGAGCCATCTTG GCACAGCGAGCAGGAGCCACGTCGGTCACCCCTGGACCCCGGGATGCTGAGTGATGACATCAAGGGACACAGACATGGATGGATGAACAGAGGAGACACAAGCAGCTTTTGACGCACCCGTCCCAGAA CCTAGGAGCAAACTGCAGGGCCCAGGACGAACCCCAATGGGTGGAACTAACTAGGGAGGCACCCAAAAGACACTACATACGACCAAAGACTATTAAACAGAACACTTGCTACCAT
hide sequence
RefSeq Acc Id:
XM_006239019 ⟹ XP_006239081
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 150,724,030 - 150,736,112 (+) NCBI mRatBN7.2 5 145,440,127 - 145,452,213 (+) NCBI Rnor_6.0 5 151,435,679 - 151,448,329 (+) NCBI Rnor_5.0 5 155,100,704 - 155,113,502 (+) NCBI
Sequence:
CTGGGAACCAAACCAGGGTCCTTTGGAAGAGCAGCAAATGCCAAATGCTCTTAACAGCTGTGCTGTCTCTCAAGCCCCAAGCTCCACCATAATAAATGATTATGAAACATGGTCCTAACCTCAGATTC CCAAAGTCTGTTTCAGGGTCCTCTAAGGTTTATACCAACTTAGTCACTATTTCATACTAGGACATTAAAGGTCCTTGGTGATTCGAAGCTGGGATACTCTTGTAACCCAAAAAGCCGAGGCTTCTGGA GTTCCTTCAAGGAATAGATAGGAAGTTTTCAGTAGAAGTGCTTCTCAGTTCCATGGGCAACTTTTGGGTGGACGGAGGATAAGTTCAGCAAGGCTTCCCAGTAAGTGACGCTATGAGGAAAGCAGCTT GTCAACGCTCAGACCTCTACCAGCAGGAACGTTTACATGTGATACCTATTACTACTCACAATGTTTTGACACCTCCCTCCCTCCCCAACCTCCCTGCTCCGCGTCCATTCATTCACTAGATCCCTGCA GGGCGGGGTCGTCCTGTTTCCTATCCCTGGCCTGGGCACACATCCTACGAGCGCCTGCAGTGAGTATTCAACAGTGTTTGGCCCGAATAGGGGCACAGGCTGTTCCGGAAGTGGACAGTGTCAGAGGT TCTAGCCGGAGAGGAGGGAGGGAGAGCCACTGGGGAGCTTCATTGCCCCAGGGCCGAGGGTGGAGCCTTTCCCAGTCGGGAAAGGGCTGGGTCCAGCCTACATGTGAGGGCAGGACAGAGTGACTGCC AGCGCTCCCTTGAGAAGTCAGGGTGTAGCACGCTGCCGGTTGAATTCCCAGGATCCTTCTGTGACCTGTGAGCCGAGGATTACTGGGTACCCCAGATTCCCAGAACCCAGTCCTGGATTGCAGATCTC TAAGGACCGTGAAAGATTAAGCAAAGATTTCTCTCTGGATTTAAGATTTCCGGAACAGGACGTCCAGCCCATCTCCGGATCCCGGCTGGATCCACACCTTCAGCCTCGTGCCCTGTCCCGGGTCTCCC GCGCCCGGCGTCCCGCGCTTGAGCGCCCCCGCATGGCGGGGCCGTGTCCCGGGGCCGGGGTTCTAGAACGGGCGGGCAGCTGCTGGCAGGACCCTCTGGCGGAGGCGCTGAGCCGGGGCCGCTCGTCT CCTGCGGTCGCCGGTCGGGGCTGCGCGCGGAGCCGGCCTCTCAGTGTGGTCTACGTGTTGACCCGCGAGCCTGGACCCGGGGTGGAGCCCGGGTCGGGAACCGAGGCAGAGCCGCTGCCGCTGCGATG CCTGCGCGAGGCCTGTGCTCAGCTCCAGAGCACGCGGCCACCCCCGCAACTGCGCAGCCTGCCCTTTGCGACGCTGGCGCTAGGCGACACCGCTGCGCTAGACTCCTTCTACAACGCGGACGTAGTGG TGCTGGAGGTGAGCAACTCCCTGGCACAGCCTTCCTTGTTCTACCACCTCGGCGTGCGTGAGAGCTTCAGCATGACCAACAATGTGCTCCTCTGTTCCCAGGCAGAGCTCCCTGACCTGCAGGCCCTT CGTGAGGATGTTTTCCAGAAGAACTCGGATTGCGTTGGCAGCTACACACTGATTCCTTATGTTGTGACAGCCACTGGCCGGGTCTTATGTGGCGATGCAGGCCTCCTGAGGGGCATAGCCGATGGGCT AGTACAGGCTGGGGTGGGCACTGAGGCCCTCCTCACGCCCCTGGTGGGCCGGCTTGTCCGTCTCTTGGAGGCCACACCCACAGACTCTTGCGGCTACTTCCGGGAGACCATTCGTCAAGATATCCGGA AGGCACGGGAGCGGTTCAGCGGGCAGCAGCTGAGGCAGGAGCTGGCTCGCCTGCAGCGGAGGCTGGACAGCGTAGAGCTGTTGAGCCCCGACATCATCATGAATCTGCTTCTGTCATACCGCGACGTC CAGGACTACTCCGCCATCATTGAGCTGGTGGAGACGCTGCAGGCTTTGCCCACCTGTGATGTGGCCGAACAGCACAATGTCTGCTTCCACTACACGTTTGCCCTCAACAGGAGGAACAGGCCTGGGGA CCGTGAGAAGGCCCTGGCTGTCCTTCTGCCATTGGTGAAGCATGAAGGCCCCGTGGCTCCAGACCTGTACTGCATGTGTGGTCGTATCTACAAGGACATGTTCTTCAGCTCCAGCTTCCAAAGTACTG GGCACCTGGAGCAGGCCTATCACTGGTACCGCAAGGCATTTGATGTGGAGCCCAGCCTACACTCGGGCATCAATGCAGCTGTGCTGCTCATTGCAGCTGGGAAACACTTTGACGACTCTGAGGAGCTC CAGCTGATAGGCATGAAGCTGGGCTGCCTGTTAGCCCGCAAAGGCTGTGTGGAGAAGATGCAGTATTACTGGGACGTGGGGTTCTACCTGGGAGCCCAGATTCTTGCCAACGACCCCATCCAGGTGGT GCTGGCTGCAGAACAACTATACAAGCTCAATGCCCCCATATGGTACTTGGTGTCAGTGATGGAGACCTTCTTACTGTACCAGCATTTCAGACCCACACCAGAGCCCTCGGGAGGACCCGTGCTGCGAG CTCACTTTTGGCTCCATTTCTTGCTACAATCCTGCCAGCCTTTCAAGGCGACCCCTCCTCAGGAGGACCAGTGCCTGGTACTGGTGCTGGAGATAAACAAGGTTCTGCTGCCTGCCAGACTTGAGATT CAGGGAGCCGACCCCATGAGCGCAGTGACCCTAAGCTTGCTGGAGCCAGAGACTCAGGATGATCCTTCCAGCTGGACCTTCCCAGTCACCTCCATCTGTGGGATCAGCGCCTCCAAGCTGGACCAGCG CTGCTGCTTCCTGTACGCACTTCCTCCGGCCCAGGACGTCCAGCTGTGCTTTCCCAGCGTAGAGCGCTGCCGGTGGTTCTGTAGCCAAATTCAGGTCTTGGTGATGAATCCAGATTCCTCGGCGCCCA CTGAGGAGGCAGAAGGCACAAGGGAGGTGCTGGAGTTTGATTATGAATATTCGGAGACGGGTGAGCGGCTGGTGCTGGGCAAAGGCACGTACGGGGTGGTGTATGCTGGCCGCGACAGGCACACGAGG GTACGAATCGCCATCAAAGAGATCCCAGAGAGAGATAGCAGATTCTCTCAGCCTCTGCACGAGGAGATCGCTCTCCACAAACGCCTTCGCCACAAGAATATAGTGCGCTATTTGGGCTCAGCCAGCCA GGGCGGCTACCTCAAGATCTTCATGGAGGAAGTGCCTGGAGGCAGCCTGTCCTCCTTGCTTAGGTCAGTGTGGGGACCCCTAAAGGACAACGAGAGTACTATTAGCTTCTACACGCGTCAGATCCTGC AAGGACTTAGCTACCTGCATGAGAACCGCATTGTTCACCGAGACATCAAGGGGGACAATGTACTGATCAACACCTTCAGTGGGCTGCTCAAGATTTCTGACTTTGGCACCTCCAAGCGGCTGGCAGGC ATCACACCCTGCACGGAGACTTTCACAGGGACCCTGCAGTATATGGCCCCAGAAATCATTGACCAGGGCCCACGAGGATATGGAAAGGCGGCTGACATCTGGTCTCTGGGCTGCACTGTGATTGAGAT GGCCACAGGTTGGCCGCCCTTTCACGAACTAGGGAGCCCGCAGGCTGCCATGTTTCAGGTGGGCATGTACAAGGTACATCCACCAGTGCCAAGTTCCCTGTCAGCTGAGGCCCAAGCCTTCCTCCTCC GAACTTTTGAGCCAGATCCCCGCCTCCGAGCCAGTGCCCAAGAGCTGTTGGGAGACCCCTTCCTGCAACCAGGGAAGAGGAGCCGCAGCCCTGGCTCTCCTCGGCACACTCCCCGGCCCTCAGGCACC CCTTCCAGTACTTCCAGTCCTTCAGCTGACTCAGCCACACAGTCTCAGACATTCCCAAGGCCCCAGGCACCCTCTCAGCACCCACCCAGCCCTCCGAAGCGCTGCCTTAGTTATGGGGACACCAGTCA GCTCCGTGTGCCCGAGGAATCCGCTGCCGAGGAACCCGCGTCCCCAGAAGAGAGTTCAGGCCTGAGCCTGCTGCACCAGGAGAGCAAGCGCCGAGCCATGCTGGCTGCAGTGCTGGAACAGGAGGTGC CCATACTAGCAGAGAATCTCCTGGATCAGGAACAGGATTCTCGACTCAGCAGGAATCATGTGGAACTTCTGCTTCGGTGCCTCGGGGCACAAATCCATACTCCTAACCGCCGGCAGCTGGCCCAGGAG CTGCGGGCCCTGCAAGCTCAACTGCGGGCCCAGAGCCTGAGCCCTGCGCTTTTGAAGGGGCCGCTCTTCGCCTTTCCAGACGCGGTGAAGCAGATCCTCCGCAGACGCCAGATCCGCCCACACTGGAT GTTCGTGTTGGACTCGCTGCTCAGCCGGGCAGTCCGGGCGGCGCTGGCCGTACTGGACGCGGAGGCAGAGAAGAAAGCGGTCTCACCGAAGTCAGAGGAGTGGAGTCAAGGGGAGTCCCAGCAGAAAC CGCTGGAGAGCCAGCCGCCGCTGCAGAGTCAGCTCCCACCAGAGCAGGAACCTCCATCCCTGATGATACAGCTGGGTCTCTTGCGAGCTGAGACTGACAGGCTTCGGGACATTCTGGCTGAGAAGGAA CGTGAGTGCCAGGCCCTCGTGCAACAGGCCCTGCATCGGGTGCACGCAGAGACCAGGACGTATGCCCTGGCTTCAGAGACCCCGGCCACTCTCCCAAAGGACCAGAAACTGGTGCAGTGGCTACAGGA CCTGAGTGTAGATCCAACCACTATCCAAACGCTCCTGAGCCATAGCTTTACCCTTCAAACCCTGCTCACCTGTGCCACTCAGGATGACCTCGTCTACACCAGAATCAGGTACATCTTGGGCCCTCCGG CGGTGAACCACGTAGCACCCGCTAGCAATATGCGGGCATCCCCTGCCCTCTGGGCCTGCCTTGATTCCTCCCTGAAAACAACTGGGGAACAAGTTCTCCTGGGCATAGCGGTTCCTAACGAGAGAGCG GGGGCTGCCTTCTGGCTGAATTACATTGATCCCTGATGTCCCCAGGGGAGGGATGGTATGCAGAATTTGGAGAGCCATCTTGGCACAGCGAGCAGGAGCCACGTCGGTCACCCCTGGACCCCGGGATG CTGAGTGATGACATCAAGGGACACAGACATGGATGGATGAACAGAGGAGACACAAGCAGCTTTTGACGCACCCGTCCCAGAACCTAGGAGCAAACTGCAGGGCCCAGGACGAACCCCAATGGGTGGAA CTAACTAGGGAGGCACCCAAAAGACACTACATACGACCAAAGACTATTAAACAGAACACTTGCTACCATA
hide sequence
RefSeq Acc Id:
XM_006239020 ⟹ XP_006239082
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 150,724,029 - 150,736,112 (+) NCBI mRatBN7.2 5 145,440,126 - 145,452,213 (+) NCBI Rnor_6.0 5 151,435,679 - 151,448,329 (+) NCBI Rnor_5.0 5 155,100,704 - 155,113,502 (+) NCBI
Sequence:
CTGGGAACCAAACCAGGGTCCTTTGGAAGAGCAGCAAATGCCAAATGCTCTTAACAGCTGTGCTGTCTCTCAAGCCCCAAGCTCCACCATAATAAATGATTATGAAACATGGTCCTAACCTCAGATTC CCAAAGTCTGTTTCAGGGTCCTCTAAGGTTTATACCAACTTAGTCACTATTTCATACTAGGACATTAAAGGTCCTTGGTGATTCGAAGCTGGGATACTCTTGTAACCCAAAAAGCCGAGGCTTCTGGA GTTCCTTCAAGGAATAGATAGGAAGTTTTCAGTAGAAGTGCTTCTCAGTTCCATGGGCAACTTTTGGGTGGACGGAGGATAAGTTCAGCAAGGCTTCCCAGTAAGTGACGCTATGAGGAAAGCAGCTT GTCAACGCTCAGACCTCTACCAGCAGGAACGTTTACATGTGATACCTATTACTACTCACAATGTTTTGACACCTCCCTCCCTCCCCAACCTCCCTGCTCCGCGTCCATTCATTCACTAGATCCCTGCA GGGCGGGGTCGTCCTGTTTCCTATCCCTGGCCTGGGCACACATCCTACGAGCGCCTGCAGTGAGTATTCAACAGTGTTTGGCCCGAATAGGGGCACAGGCTGTTCCGGAAGTGGACAGTGTCAGAGGT TCTAGCCGGAGAGGAGGGAGGGAGAGCCACTGGGGAGCTTCATTGCCCCAGGGCCGAGGGTGGAGCCTTTCCCAGTCGGGAAAGGGCTGGGTCCAGCCTACATGTGAGGGCAGGACAGAGTGACTGCC AGCGCTCCCTTGAGAAGTCAGGGTGTAGCACGCTGCCGGTTGAATTCCCAGGATCCTTCTGTGACCTGTGAGCCGAGGATTACTGGGTACCCCAGATTCCCAGAACCCAGTCCTGGATTGCAGATCTC TAAGGACCGTGAAAGATTAAGCAAAGATTTCTCTCTGGATTTAAGATTTCCGGAACAGGACGTCCAGCCCATCTCCGGATCCCGGCTGGATCCACACCTTCAGCCTCGTGCCCTGTCCCGGGTCTCCC GCGCCCGGCGTCCCGCGCTTGAGCGCCCCCGCATGGCGGGGCCGTGTCCCGGGGCCGGGGTTCTAGAACGGGCGGGCAGCTGCTGGCAGGACCCTCTGGCGGAGGCGCTGAGCCGGGGCCGCTCGTCT CCTGCGGTCGCCGGTCGGGGCTGCGCGCGGAGCCGGCCTCTCAGTGTGGTCTACGTGTTGACCCGCGAGCCTGGACCCGGGGTGGAGCCCGGGTCGGGAACCGAGGCAGAGCCGCTGCCGCTGCGATG CCTGCGCGAGGCCTGTGCTCAGCTCCAGAGCACGCGGCCACCCCCGCAACTGCGCAGCCTGCCCTTTGCGACGCTGGCGCTAGGCGACACCGCTGCGCTAGACTCCTTCTACAACGCGGACGTAGTGG TGCTGGAGGTGAGCAACTCCCTGGCACAGCCTTCCTTGTTCTACCACCTCGGCGTGCGTGAGAGCTTCAGCATGACCAACAATGTGCTCCTCTGTTCCCAGGCAGAGCTCCCTGACCTGCAGGCCCTT CGTGATTGCGTTGGCAGCTACACACTGATTCCTTATGTTGTGACAGCCACTGGCCGGGTCTTATGTGGCGATGCAGGCCTCCTGAGGGGCATAGCCGATGGGCTAGTACAGGCTGGGGTGGGCACTGA GGCCCTCCTCACGCCCCTGGTGGGCCGGCTTGTCCGTCTCTTGGAGGCCACACCCACAGACTCTTGCGGCTACTTCCGGGAGACCATTCGTCAAGATATCCGGAAGGCACGGGAGCGGTTCAGCGGGC AGCAGCTGAGGCAGGAGCTGGCTCGCCTGCAGCGGAGGCTGGACAGCGTAGAGCTGTTGAGCCCCGACATCATCATGAATCTGCTTCTGTCATACCGCGACGTCCAGGACTACTCCGCCATCATTGAG CTGGTGGAGACGCTGCAGGCTTTGCCCACCTGTGATGTGGCCGAACAGCACAATGTCTGCTTCCACTACACGTTTGCCCTCAACAGGAGGAACAGGCCTGGGGACCGTGAGAAGGCCCTGGCTGTCCT TCTGCCATTGGTGAAGCATGAAGGCCCCGTGGCTCCAGACCTGTACTGCATGTGTGGTCGTATCTACAAGGACATGTTCTTCAGCTCCAGCTTCCAAAGTACTGGGCACCTGGAGCAGGCCTATCACT GGTACCGCAAGGCATTTGATGTGGAGCCCAGCCTACACTCGGGCATCAATGCAGCTGTGCTGCTCATTGCAGCTGGGAAACACTTTGACGACTCTGAGGAGCTCCAGCTGATAGGCATGAAGCTGGGC TGCCTGTTAGCCCGCAAAGGCTGTGTGGAGAAGATGCAGTATTACTGGGACGTGGGGTTCTACCTGGGAGCCCAGATTCTTGCCAACGACCCCATCCAGGTGGTGCTGGCTGCAGAACAACTATACAA GCTCAATGCCCCCATATGGTACTTGGTGTCAGTGATGGAGACCTTCTTACTGTACCAGCATTTCAGACCCACACCAGAGCCCTCGGGAGGACCCGTGCTGCGAGCTCACTTTTGGCTCCATTTCTTGC TACAATCCTGCCAGCCTTTCAAGGCGACCCCTCCTCAGGAGGACCAGTGCCTGGTACTGGTGCTGGAGATAAACAAGGTTCTGCTGCCTGCCAGACTTGAGATTCAGGGAGCCGACCCCATGAGCGCA GTGACCCTAAGCTTGCTGGAGCCAGAGACTCAGGATGATCCTTCCAGCTGGACCTTCCCAGTCACCTCCATCTGTGGGATCAGCGCCTCCAAGCTGGACCAGCGCTGCTGCTTCCTGTACGCACTTCC TCCGGCCCAGGACGTCCAGCTGTGCTTTCCCAGCGTAGAGCGCTGCCGGTGGTTCTGTAGCCAAATTCAGGTCTTGGTGATGAATCCAGATTCCTCGGCGCCCACTGAGGAGGCAGAAGGCACAAGGG AGGTGCTGGAGTTTGATTATGAATATTCGGAGACGGGTGAGCGGCTGGTGCTGGGCAAAGGCACGTACGGGGTGGTGTATGCTGGCCGCGACAGGCACACGAGGGTACGAATCGCCATCAAAGAGATC CCAGAGAGAGATAGCAGATTCTCTCAGCCTCTGCACGAGGAGATCGCTCTCCACAAACGCCTTCGCCACAAGAATATAGTGCGCTATTTGGGCTCAGCCAGCCAGGGCGGCTACCTCAAGATCTTCAT GGAGGAAGTGCCTGGAGGCAGCCTGTCCTCCTTGCTTAGGTCAGTGTGGGGACCCCTAAAGGACAACGAGAGTACTATTAGCTTCTACACGCGTCAGATCCTGCAAGGACTTAGCTACCTGCATGAGA ACCGCATTGTTCACCGAGACATCAAGGGGGACAATGTACTGATCAACACCTTCAGTGGGCTGCTCAAGATTTCTGACTTTGGCACCTCCAAGCGGCTGGCAGGCATCACACCCTGCACGGAGACTTTC ACAGGGACCCTGCAGTATATGGCCCCAGAAATCATTGACCAGGGCCCACGAGGATATGGAAAGGCGGCTGACATCTGGTCTCTGGGCTGCACTGTGATTGAGATGGCCACAGGTTGGCCGCCCTTTCA CGAACTAGGGAGCCCGCAGGCTGCCATGTTTCAGGTGGGCATGTACAAGGTACATCCACCAGTGCCAAGTTCCCTGTCAGCTGAGGCCCAAGCCTTCCTCCTCCGAACTTTTGAGCCAGATCCCCGCC TCCGAGCCAGTGCCCAAGAGCTGTTGGGAGACCCCTTCCTGCAACCAGGGAAGAGGAGCCGCAGCCCTGGCTCTCCTCGGCACACTCCCCGGCCCTCAGGCACCCCTTCCAGTACTTCCAGTCCTTCA GCTGACTCAGCCACACAGTCTCAGACATTCCCAAGGCCCCAGGCACCCTCTCAGCACCCACCCAGCCCTCCGAAGCGCTGCCTTAGTTATGGGGACACCAGTCAGCTCCGTGTGCCCGAGGAATCCGC TGCCGAGGAACCCGCGTCCCCAGAAGAGAGTTCAGGCCTGAGCCTGCTGCACCAGGAGAGCAAGCGCCGAGCCATGCTGGCTGCAGTGCTGGAACAGGAGGTGCCCATACTAGCAGAGAATCTCCTGG ATCAGGAACAGGATTCTCGACTCAGCAGGAATCATGTGGAACTTCTGCTTCGGTGCCTCGGGGCACAAATCCATACTCCTAACCGCCGGCAGCTGGCCCAGGAGCTGCGGGCCCTGCAAGCTCAACTG CGGGCCCAGAGCCTGAGCCCTGCGCTTTTGAAGGGGCCGCTCTTCGCCTTTCCAGACGCGGTGAAGCAGATCCTCCGCAGACGCCAGATCCGCCCACACTGGATGTTCGTGTTGGACTCGCTGCTCAG CCGGGCAGTCCGGGCGGCGCTGGCCGTACTGGACGCGGAGGCAGAGAAGAAAGCGGTCTCACCGAAGTCAGAGGAGTGGAGTCAAGGGGAGTCCCAGCAGAAACCGCTGGAGAGCCAGCCGCCGCTGC AGAGTCAGCTCCCACCAGAGCAGGAACCTCCATCCCTGATGATACAGCTGGGTCTCTTGCGAGCTGAGACTGACAGGCTTCGGGACATTCTGGCTGAGAAGGAACGTGAGTGCCAGGCCCTCGTGCAA CAGGCCCTGCATCGGGTGCACGCAGAGACCAGGACGTATGCCCTGGCTTCAGAGACCCCGGCCACTCTCCCAAAGGACCAGAAACTGGTGCAGTGGCTACAGGACCTGAGTGTAGATCCAACCACTAT CCAAACGCTCCTGAGCCATAGCTTTACCCTTCAAACCCTGCTCACCTGTGCCACTCAGGATGACCTCGTCTACACCAGAATCAGGTACATCTTGGGCCCTCCGGCGGTGAACCACGTAGCACCCGCTA GCAATATGCGGGCATCCCCTGCCCTCTGGGCCTGCCTTGATTCCTCCCTGAAAACAACTGGGGAACAAGTTCTCCTGGGCATAGCGGTTCCTAACGAGAGAGCGGGGGCTGCCTTCTGGCTGAATTAC ATTGATCCCTGATGTCCCCAGGGGAGGGATGGTATGCAGAATTTGGAGAGCCATCTTGGCACAGCGAGCAGGAGCCACGTCGGTCACCCCTGGACCCCGGGATGCTGAGTGATGACATCAAGGGACAC AGACATGGATGGATGAACAGAGGAGACACAAGCAGCTTTTGACGCACCCGTCCCAGAACCTAGGAGCAAACTGCAGGGCCCAGGACGAACCCCAATGGGTGGAACTAACTAGGGAGGCACCCAAAAGA CACTACATACGACCAAAGACTATTAAACAGAACACTTGCTACCATA
hide sequence
RefSeq Acc Id:
XM_006239022 ⟹ XP_006239084
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 150,724,927 - 150,736,112 (+) NCBI mRatBN7.2 5 145,441,024 - 145,452,213 (+) NCBI Rnor_6.0 5 151,437,518 - 151,448,329 (+) NCBI Rnor_5.0 5 155,100,704 - 155,113,502 (+) NCBI
Sequence:
GTTGATAAGTCCTAACTTTACTACATCCCACACGGGGCTAAAGGGGCGGAAATGGAAGCGCTGA GGCAACCCTTCGGGACTGGATTATTGGAGAGAGGGATTGTGTTTGGAGACTAGGAGACTAGGAAAGAAAATGGACAGGGTAGAGGTGGGTCTAGAAGAGAGACAGGGAGTCCAGGGGCGAGGTCGGAA GGTGGCTATTCCTCTCTTTTCCACCTACCCGGATGCTCCACCCCATCCCTATTTGTTCATCCCAGAGTCAGAGAGCCGTGTATCCTGGACATCTGCTAAATTGTAGCTTAAAAATGAAGGCTGATCCG ATCAGACCACAGATAAAGTCATGGACTCATCCCCGATGACTCATACAGTCCCCTCCCTCGTGGACACTGCCACTTAAAGATGGCTGGTTATAGTAAGCTACACAAACACACATAAAAGCACAACATTG TCTTCACACAGGACGGTGCAGATCACCCTCAAGGGCCGGTCTTCAAGGCTGGAGAGATGGCCTAGAGGTTAAGAGCACTTGCTGCTCCCAGCATGCACATGGGGTGCTCATAACCACCTATAACTTTA TCTCCAGAGGATCCCAATGCTGTCTTCTATCATACACTCACACCAACACACGCATTCATATAAATAAAATGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGACTTCTGTTTGCAAGGTTCCTATCT CCTCATAGCCTGGAAGTGCCTAGCCAGAGCACCACCACTTATCTCCTTCCTGGGACTTCTAGGCTCTCGGTGCGATGGGGGTCTCTGGGCATCTTCTGTAACACCACCATTCCGAGTATTGTGAAAAC ATCATCGGGAGGGAAGCTCTCTAGAGCAGCACTGAACTTGGCATCAGGGGCAGGCAAGGCAAGCACCTCTAGGCTCCTTCACCTCTGAGCTGTGCTCGACGCTCAGGTCTACACTTCTGTGTCCACAG ACGTAGTGGTGCTGGAGGTGAGCAACTCCCTGGCACAGCCTTCCTTGTTCTACCACCTCGGCGTGCGTGAGAGCTTCAGCATGACCAACAATGTGCTCCTCTGTTCCCAGGCAGAGCTCCCTGACCTG CAGGCCCTTCGTGAGGATGTTTTCCAGAAGAACTCGCGGCTACTTCCGGGAGACCATTCGTCAAGATATCCGGAAGGCACGGGAGCGGTTCAGCGGGCAGCAGCTGAGGCAGGAGCTGGCTCGCCTGC AGCGGAGGCTGGACAGCGTAGAGCTGTTGAGCCCCGACATCATCATGAATCTGCTTCTGTCATACCGCGACGTCCAGGACTACTCCGCCATCATTGAGCTGGTGGAGACGCTGCAGGCTTTGCCCACC TGTGATGTGGCCGAACAGCACAATGTCTGCTTCCACTACACGTTTGCCCTCAACAGGAGGAACAGGCCTGGGGACCGTGAGAAGGCCCTGGCTGTCCTTCTGCCATTGGTGAAGCATGAAGGCCCCGT GGCTCCAGACCTGTACTGCATGTGTGGTCGTATCTACAAGGACATGTTCTTCAGCTCCAGCTTCCAAAGTACTGGGCACCTGGAGCAGGCCTATCACTGGTACCGCAAGGCATTTGATGTGGAGCCCA GCCTACACTCGGGCATCAATGCAGCTGTGCTGCTCATTGCAGCTGGGAAACACTTTGACGACTCTGAGGAGCTCCAGCTGATAGGCATGAAGCTGGGCTGCCTGTTAGCCCGCAAAGGCTGTGTGGAG AAGATGCAGTATTACTGGGACGTGGGGTTCTACCTGGGAGCCCAGATTCTTGCCAACGACCCCATCCAGGTGGTGCTGGCTGCAGAACAACTATACAAGCTCAATGCCCCCATATGGTACTTGGTGTC AGTGATGGAGACCTTCTTACTGTACCAGCATTTCAGACCCACACCAGAGCCCTCGGGAGGACCCGTGCTGCGAGCTCACTTTTGGCTCCATTTCTTGCTACAATCCTGCCAGCCTTTCAAGGCGACCC CTCCTCAGGAGGACCAGTGCCTGGTACTGGTGCTGGAGATAAACAAGGTTCTGCTGCCTGCCAGACTTGAGATTCAGGGAGCCGACCCCATGAGCGCAGTGACCCTAAGCTTGCTGGAGCCAGAGACT CAGGATGATCCTTCCAGCTGGACCTTCCCAGTCACCTCCATCTGTGGGATCAGCGCCTCCAAGCTGGACCAGCGCTGCTGCTTCCTGTACGCACTTCCTCCGGCCCAGGACGTCCAGCTGTGCTTTCC CAGCGTAGAGCGCTGCCGGTGGTTCTGTAGCCAAATTCAGGTCTTGGTGATGAATCCAGATTCCTCGGCGCCCACTGAGGAGGCAGAAGGCACAAGGGAGGTGCTGGAGTTTGATTATGAATATTCGG AGACGGGTGAGCGGCTGGTGCTGGGCAAAGGCACGTACGGGGTGGTGTATGCTGGCCGCGACAGGCACACGAGGGTACGAATCGCCATCAAAGAGATCCCAGAGAGAGATAGCAGATTCTCTCAGCCT CTGCACGAGGAGATCGCTCTCCACAAACGCCTTCGCCACAAGAATATAGTGCGCTATTTGGGCTCAGCCAGCCAGGGCGGCTACCTCAAGATCTTCATGGAGGAAGTGCCTGGAGGCAGCCTGTCCTC CTTGCTTAGGTCAGTGTGGGGACCCCTAAAGGACAACGAGAGTACTATTAGCTTCTACACGCGTCAGATCCTGCAAGGACTTAGCTACCTGCATGAGAACCGCATTGTTCACCGAGACATCAAGGGGG ACAATGTACTGATCAACACCTTCAGTGGGCTGCTCAAGATTTCTGACTTTGGCACCTCCAAGCGGCTGGCAGGCATCACACCCTGCACGGAGACTTTCACAGGGACCCTGCAGTATATGGCCCCAGAA ATCATTGACCAGGGCCCACGAGGATATGGAAAGGCGGCTGACATCTGGTCTCTGGGCTGCACTGTGATTGAGATGGCCACAGGTTGGCCGCCCTTTCACGAACTAGGGAGCCCGCAGGCTGCCATGTT TCAGGTGGGCATGTACAAGGTACATCCACCAGTGCCAAGTTCCCTGTCAGCTGAGGCCCAAGCCTTCCTCCTCCGAACTTTTGAGCCAGATCCCCGCCTCCGAGCCAGTGCCCAAGAGCTGTTGGGAG ACCCCTTCCTGCAACCAGGGAAGAGGAGCCGCAGCCCTGGCTCTCCTCGGCACACTCCCCGGCCCTCAGGCACCCCTTCCAGTACTTCCAGTCCTTCAGCTGACTCAGCCACACAGTCTCAGACATTC CCAAGGCCCCAGGCACCCTCTCAGCACCCACCCAGCCCTCCGAAGCGCTGCCTTAGTTATGGGGACACCAGTCAGCTCCGTGTGCCCGAGGAATCCGCTGCCGAGGAACCCGCGTCCCCAGAAGAGAG TTCAGGCCTGAGCCTGCTGCACCAGGAGAGCAAGCGCCGAGCCATGCTGGCTGCAGTGCTGGAACAGGAGGTGCCCATACTAGCAGAGAATCTCCTGGATCAGGAACAGGATTCTCGACTCAGCAGGA ATCATGTGGAACTTCTGCTTCGGTGCCTCGGGGCACAAATCCATACTCCTAACCGCCGGCAGCTGGCCCAGGAGCTGCGGGCCCTGCAAGCTCAACTGCGGGCCCAGAGCCTGAGCCCTGCGCTTTTG AAGGGGCCGCTCTTCGCCTTTCCAGACGCGGTGAAGCAGATCCTCCGCAGACGCCAGATCCGCCCACACTGGATGTTCGTGTTGGACTCGCTGCTCAGCCGGGCAGTCCGGGCGGCGCTGGCCGTACT GGACGCGGAGGCAGAGAAGAAAGCGGTCTCACCGAAGTCAGAGGAGTGGAGTCAAGGGGAGTCCCAGCAGAAACCGCTGGAGAGCCAGCCGCCGCTGCAGAGTCAGCTCCCACCAGAGCAGGAACCTC CATCCCTGATGATACAGCTGGGTCTCTTGCGAGCTGAGACTGACAGGCTTCGGGACATTCTGGCTGAGAAGGAACGTGAGTGCCAGGCCCTCGTGCAACAGGCCCTGCATCGGGTGCACGCAGAGACC AGGACGTATGCCCTGGCTTCAGAGACCCCGGCCACTCTCCCAAAGGACCAGAAACTGGTGCAGTGGCTACAGGACCTGAGTGTAGATCCAACCACTATCCAAACGCTCCTGAGCCATAGCTTTACCCT TCAAACCCTGCTCACCTGTGCCACTCAGGATGACCTCGTCTACACCAGAATCAGGTACATCTTGGGCCCTCCGGCGGTGAACCACGTAGCACCCGCTAGCAATATGCGGGCATCCCCTGCCCTCTGGG CCTGCCTTGATTCCTCCCTGAAAACAACTGGGGAACAAGTTCTCCTGGGCATAGCGGTTCCTAACGAGAGAGCGGGGGCTGCCTTCTGGCTGAATTACATTGATCCCTGATGTCCCCAGGGGAGGGAT GGTATGCAGAATTTGGAGAGCCATCTTGGCACAGCGAGCAGGAGCCACGTCGGTCACCCCTGGACCCCGGGATGCTGAGTGATGACATCAAGGGACACAGACATGGATGGATGAACAGAGGAGACACA AGCAGCTTTTGACGCACCCGTCCCAGAACCTAGGAGCAAACTGCAGGGCCCAGGACGAACCCCAATGGGTGGAACTAACTAGGGAGGCACCCAAAAGACACTACATACGACCAAAGACTATTAAACAG AACACTTGCTACCATA
hide sequence
RefSeq Acc Id:
XM_008764137 ⟹ XP_008762359
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 150,724,047 - 150,736,112 (+) NCBI mRatBN7.2 5 145,440,154 - 145,452,213 (+) NCBI Rnor_6.0 5 151,435,692 - 151,448,329 (+) NCBI
Sequence:
CAGGGTCCTTTGGAAGAGCAGCAAATGCCAAATGCTCTTAACAGCTGTGCTGTCTCTCAAGCCC CAAGCTCCACCATAATAAATGATTATGAAACATGGTCCTAACCTCAGATTCCCAAAGTCTGTTTCAGGGTCCTCTAAGGTTTATACCAACTTAGTCACTATTTCATACTAGGACATTAAAGGTCCTTG GTGATTCGAAGCTGGGATACTCTTGTAACCCAAAAAGCCGAGGCTTCTGGAGTTCCTTCAAGGAATAGATAGGAAGTTTTCAGTAGAAGTGCTTCTCAGTTCCATGGGCAACTTTTGGGTGGACGGAG GATAAGTTCAGCAAGGCTTCCCAGTAAGTGACGCTATGAGGAAAGCAGCTTGTCAACGCTCAGACCTCTACCAGCAGGAACGTTTACATGTGATACCTATTACTACTCACAATGTTTTGACACCTCCC TCCCTCCCCAACCTCCCTGCTCCGCGTCCATTCATTCACTAGATCCCTGCAGGGCGGGGTCGTCCTGTTTCCTATCCCTGGCCTGGGCACACATCCTACGAGCGCCTGCAGTGAGTATTCAACAGTGT TTGGCCCGAATAGGGGCACAGGCTGTTCCGGAAGTGGACAGTGTCAGAGGTTCTAGCCGGAGAGGAGGGAGGGAGAGCCACTGGGGAGCTTCATTGCCCCAGGGCCGAGGGTGGAGCCTTTCCCAGTC GGGAAAGGGCTGGGTCCAGCCTACATGTGAGGGCAGGACAGAGTGACTGCCAGCGCTCCCTTGAGAAGTCAGGGTGTAGCACGCTGCCGGTTGAATTCCCAGGATCCTTCTGTGACCTGTGAGCCGAG GATTACTGGGTACCCCAGATTCCCAGAACCCAGTCCTGGATTGCAGATCTCTAAGGACCGTGAAAGATTAAGCAAAGATTTCTCTCTGGATTTAAGATTTCCGGAACAGGACGTCCAGCCCATCTCCG GATCCCGGCTGGATCCACACCTTCAGCCTCGTGCCCTGTCCCGGGTCTCCCGCGCCCGGCGTCCCGCGCTTGAGCGCCCCCGCATGGCGGGGCCGTGTCCCGGGGCCGGGGTTCTAGAACGGGCGGGC AGCTGCTGGCAGGACCCTCTGGCGGAGGCGCTGAGCCGGGGCCGCTCGTCTCCTGCGGTCGCCGGTCGGGGCTGCGCGCGGAGCCGGCCTCTCAGTGTGGTCTACGTGTTGACCCGCGAGCCTGGACC CGGGGTGGAGCCCGGGTCGGGAACCGAGGCAGAGCCGCTGCCGCTGCGATGCCTGCGCGAGGCCTGTGCTCAGCTCCAGAGCACGCGGCCACCCCCGCAACTGCGCAGCCTGCCCTTTGCGACGCTGG CGCTAGGCGACACCGCTGCGCTAGACTCCTTCTACAACGCGGACGTAGTGGTGCTGGAGGTGAGCAACTCCCTGGCACAGCCTTCCTTGTTCTACCACCTCGGCGTGCGTGAGAGCTTCAGCATGACC AACAATGTGCTCCTCTGTTCCCAGGCAGAGCTCCCTGACCTGCAGGCCCTTCGTGATTGCGTTGGCAGCTACACACTGATTCCTTATGTTGTGACAGCCACTGGCCGGGTCTTATGTGGCGATGCAGG CCTCCTGAGGGGCATAGCCGATGGGCTAGTACAGGCTGGGGTGGGCACTGAGGCCCTCCTCACGCCCCTGGTGGGCCGGCTTGTCCGTCTCTTGGAGGCCACACCCACAGACTCTTGCGGCTACTTCC GGGAGACCATTCGTCAAGATATCCGGAAGGCACGGGAGCGGTTCAGCGGGCAGCAGCTGAGGCAGGAGCTGGCTCGCCTGCAGCGGAGGCTGGACAGCGTAGAGCTGTTGAGCCCCGACATCATCATG AATCTGCTTCTGTCATACCGCGACGTCCAGGACTACTCCGCCATCATTGAGCTGGTGGAGACGCTGCAGGCTTTGCCCACCTGTGATGTGGCCGAACAGCACAATGTCTGCTTCCACTACACGTTTGC CCTCAACAGGAGGAACAGGCCTGGGGACCGTGAGAAGGCCCTGGCTGTCCTTCTGCCATTGGTGAAGCATGAAGGCCCCGTGGCTCCAGACCTGTACTGCATGTGTGGTCGTATCTACAAGGACATGT TCTTCAGCTCCAGCTTCCAAAGTACTGGGCACCTGGAGCAGGCCTATCACTGGTACCGCAAGGCATTTGATGTGGAGCCCAGCCTACACTCGGGCATCAATGCAGCTGTGCTGCTCATTGCAGCTGGG AAACACTTTGACGACTCTGAGGAGCTCCAGCTGATAGGCATGAAGCTGGGCTGCCTGTTAGCCCGCAAAGGCTGTGTGGAGAAGATGCAGTATTACTGGGACGTGGGGTTCTACCTGGGAGCCCAGAT TCTTGCCAACGACCCCATCCAGGTGGTGCTGGCTGCAGAACAACTATACAAGCTCAATGCCCCCATATGGTACTTGGTGTCAGTGATGGAGACCTTCTTACTGTACCAGCATTTCAGACCCACACCAG AGCCCTCGGGAGGACCCGTGCTGCGAGCTCACTTTTGGCTCCATTTCTTGCTACAATCCTGCCAGCCTTTCAAGGCGACCCCTCCTCAGGAGGACCAGTGCCTGGTACTGGTGCTGGAGATAAACAAG GTTCTGCTGCCTGCCAGACTTGAGATTCAGGGAGCCGACCCCATGAGCGCAGTGACCCTAAGCTTGCTGGAGCCAGAGACTCAGGATGATCCTTCCAGCTGGACCTTCCCAGTCACCTCCATCTGTGG GATCAGCGCCTCCAAGCTGGACCAGCGCTGCTGCTTCCTGTACGCACTTCCTCCGGCCCAGGACGTCCAGCTGTGCTTTCCCAGCGTAGAGCGCTGCCGGTGGTTCTGTAGCCAAATTCAGGTCTTGG TGATGAATCCAGATTCCTCGGCGCCCACTGAGGAGGCAGAAGGCACAAGGGAGGTGCTGGAGTTTGATTATGAATATTCGGAGACGGGTGAGCGGCTGGTGCTGGGCAAAGGCACGTACGGGGTGGTG TATGCTGGCCGCGACAGGCACACGAGGGTACGAATCGCCATCAAAGAGATCCCAGAGAGAGATAGCAGATTCTCTCAGCCTCTGCACGAGGAGATCGCTCTCCACAAACGCCTTCGCCACAAGAATAT AGTGCGCTATTTGGGCTCAGCCAGCCAGGGCGGCTACCTCAAGATCTTCATGGAGGAAGTGCCTGGAGGCAGCCTGTCCTCCTTGCTTAGGTCAGTGTGGGGACCCCTAAAGGACAACGAGAGTACTA TTAGCTTCTACACGCGTCAGATCCTGCAAGGACTTAGCTACCTGCATGAGAACCGCATTGTTCACCGAGACATCAAGGGGGACAATGTACTGATCAACACCTTCAGTGGGCTGCTCAAGATTTCTGAC TTTGGCACCTCCAAGCGGCTGGCAGGCATCACACCCTGCACGGAGACTTTCACAGGGACCCTGCAGTATATGGCCCCAGAAATCATTGACCAGGGCCCACGAGGATATGGAAAGGCGGCTGACATCTG GTCTCTGGGCTGCACTGTGATTGAGATGGCCACAGGTTGGCCGCCCTTTCACGAACTAGGGAGCCCGCAGGCTGCCATGTTTCAGGTGGGCATGTACAAGGTACATCCACCAGTGCCAAGTTCCCTGT CAGCTGAGGCCCAAGCCTTCCTCCTCCGAACTTTTGAGCCAGATCCCCGCCTCCGAGCCAGTGCCCAAGAGCTGTTGGGAGACCCCTTCCTGCAACCAGGGAAGAGGAGCCGCAGCCCTGGCTCTCCT CGGCACACTCCCCGGCCCTCAGGCACCCCTTCCAGTACTTCCAGTCCTTCAGCTGACTCAGCCACACAGTCTCAGACATTCCCAAGGCCCCAGGCACCCTCTCAGCACCCACCCAGCCCTCCGAAGCG CTGCCTTAGTTATGGGGACACCAGTCAGCTCCGTGTGCCCGAGGAATCCGCTGCCGAGGAACCCGCGTCCCCAGAAGAGAGTTCAGGCCTGAGCCTGCTGCACCAGGAGAGCAAGCGCCGAGCCATGC TGGCTGCAGTGCTGGAACAGGAGGTGCCCATACTAGCAGAGAATCTCCTGGATCAGGAACAGGATTCTCGACTCAGCAGGAATCATGTGGAACTTCTGCTTCGGTGCCTCGGGGCACAAATCCATACT CCTAACCGCCGGCAGCTGGCCCAGGAGCTGCGGGCCCTGCAAGCTCAACTGCGGGCCCAGAGCCTGAGCCCTGCGCTTTTGAAGGGGCCGCTCTTCGCCTTTCCAGACGCGGTGAAGCAGATCCTCCG CAGACGCCAGATCCGCCCACACTGGATGTTCGTGTTGGACTCGCTGCTCAGCCGGGCAGTCCGGGCGGCGCTGGCCGTACTGGACGCGGAGGCAGAGAAGAAAGCGGTCTCACCGAAGTCAGAGGAGT GGAGTCAAGGGGAGTCCCAGCAGAAACCGCTGGAGAGCCAGCCGCCGCTGCAGAGTCAGCTCCCACCAGAGCAGGAACCTCCATCCCTGATGATACAGCTGGGTCTCTTGCGAGCTGAGACTGACAGG CTTCGGGACATTCTGGCTGAGAAGGAACGTGAGTGCCAGGCCCTCGTGCAACAGGCCCTGCATCGGGTGCACGCAGAGACCAGGACGTATGCCCTGGCTTCAGAGACCCCGGCCACTCTCCCAAAGGA CCAGAAACTGGTGCAGTGGCTACAGGACCTGAGTGTAGATCCAACCACTATCCAAACGCTCCTGAGCCATAGCTTTACCCTTCAAACCCTGCTCACCTGTGCCACTCAGGATGACCTCGTCTACACCA GAATCAGGGGAGGGATGGTATGCAGAATTTGGAGAGCCATCTTGGCACAGCGAGCAGGAGCCACGTCGGTCACCCCTGGACCCCGGGATGCTGAGTGATGACATCAAGGGACACAGACATGGATGGAT GAACAGAGGAGACACAAGCAGCTTTTGACGCACCCGTCCCAGAACCTAGGAGCAAACTGCAGGGCCCAGGACGAACCCCAATGGGTGGAACTAACTAGGGAGGCACCCAAAAGACACTACATACGACC AAAGACTATTAAACAGAACACTTGCTACCATA
hide sequence
RefSeq Acc Id:
XM_039109779 ⟹ XP_038965707
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 150,724,717 - 150,736,112 (+) NCBI mRatBN7.2 5 145,440,821 - 145,452,213 (+) NCBI
RefSeq Acc Id:
NP_001101379 ⟸ NM_001107909
- UniProtKB:
D3ZFL3 (UniProtKB/TrEMBL), A6ISW1 (UniProtKB/TrEMBL)
- Sequence:
MAGPCPGAGVLERAGSCWQDPLAEALSRGRSSPAVAGRGCARSRPLSVVYVLTREPGPGVEPGSGTEAEPLPLRCLREACAQLQSTRPPPQLRSLPFATLALGDTAALDSFYNADVVVLEVSNSLAQP SLFYHLGVRESFSMTNNVLLCSQAELPDLQALREDVFQKNSDCVGSYTLIPYVVTATGRVLCGDAGLLRGIADGLVQAGVGTEALLTPLVGRLVRLLEATPTDSCGYFRETIRQDIRKARERFSGQQL RQELARLQRRLDSVELLSPDIIMNLLLSYRDVQDYSAIIELVETLQALPTCDVAEQHNVCFHYTFALNRRNRPGDREKALAVLLPLVKHEGPVAPDLYCMCGRIYKDMFFSSSFQSTGHLEQAYHWYR KAFDVEPSLHSGINAAVLLIAAGKHFDDSEELQLIGMKLGCLLARKGCVEKMQYYWDVGFYLGAQILANDPIQVVLAAEQLYKLNAPIWYLVSVMETFLLYQHFRPTPEPSGGPVLRAHFWLHFLLQS CQPFKATPPQEDQCLVLVLEINKVLLPARLEIQGADPMSAVTLSLLEPETQDDPSSWTFPVTSICGISASKLDQRCCFLYALPPAQDVQLCFPSVERCRWFCSQIQVLVMNPDSSAPTEEAEGTREVL EFDYEYSETGERLVLGKGTYGVVYAGRDRHTRVRIAIKEIPERDSRFSQPLHEEIALHKRLRHKNIVRYLGSASQGGYLKIFMEEVPGGSLSSLLRSVWGPLKDNESTISFYTRQILQGLSYLHENRI VHRDIKGDNVLINTFSGLLKISDFGTSKRLAGITPCTETFTGTLQYMAPEIIDQGPRGYGKAADIWSLGCTVIEMATGWPPFHELGSPQAAMFQVGMYKVHPPVPSSLSAEAQAFLLRTFEPDPRLRA SAQELLGDPFLQPGKRSRSPGSPRHTPRPSGTPSSTSSPSADSATQSQTFPRPQAPSQHPPSPPKRCLSYGDTSQLRVPEESAAEEPASPEESSGLSLLHQESKRRAMLAAVLEQEVPILAENLLDQE QDSRLSRNHVELLLRCLGAQIHTPNRRQLAQELRALQAQLRAQSLSPALLKGPLFAFPDAVKQILRRRQIRPHWMFVLDSLLSRAVRAALAVLDAEAEKKAVSPKSEEWSQGESQQKPLESQPPLQSQ LPPEQEPPSLMIQLGLLRAETDRLRDILAEKERECQALVQQALHRVHAETRTYALASETPATLPKDQKLVQWLQDLSVDPTTIQTLLSHSFTLQTLLTCATQDDLVYTRIRGGMVCRIWRAILAQRAG ATSVTPGPRDAE
hide sequence
RefSeq Acc Id:
XP_006239081 ⟸ XM_006239019
- Peptide Label:
isoform X1
- Sequence:
MAGPCPGAGVLERAGSCWQDPLAEALSRGRSSPAVAGRGCARSRPLSVVYVLTREPGPGVEPGS GTEAEPLPLRCLREACAQLQSTRPPPQLRSLPFATLALGDTAALDSFYNADVVVLEVSNSLAQPSLFYHLGVRESFSMTNNVLLCSQAELPDLQALREDVFQKNSDCVGSYTLIPYVVTATGRVLCGD AGLLRGIADGLVQAGVGTEALLTPLVGRLVRLLEATPTDSCGYFRETIRQDIRKARERFSGQQLRQELARLQRRLDSVELLSPDIIMNLLLSYRDVQDYSAIIELVETLQALPTCDVAEQHNVCFHYT FALNRRNRPGDREKALAVLLPLVKHEGPVAPDLYCMCGRIYKDMFFSSSFQSTGHLEQAYHWYRKAFDVEPSLHSGINAAVLLIAAGKHFDDSEELQLIGMKLGCLLARKGCVEKMQYYWDVGFYLGA QILANDPIQVVLAAEQLYKLNAPIWYLVSVMETFLLYQHFRPTPEPSGGPVLRAHFWLHFLLQSCQPFKATPPQEDQCLVLVLEINKVLLPARLEIQGADPMSAVTLSLLEPETQDDPSSWTFPVTSI CGISASKLDQRCCFLYALPPAQDVQLCFPSVERCRWFCSQIQVLVMNPDSSAPTEEAEGTREVLEFDYEYSETGERLVLGKGTYGVVYAGRDRHTRVRIAIKEIPERDSRFSQPLHEEIALHKRLRHK NIVRYLGSASQGGYLKIFMEEVPGGSLSSLLRSVWGPLKDNESTISFYTRQILQGLSYLHENRIVHRDIKGDNVLINTFSGLLKISDFGTSKRLAGITPCTETFTGTLQYMAPEIIDQGPRGYGKAAD IWSLGCTVIEMATGWPPFHELGSPQAAMFQVGMYKVHPPVPSSLSAEAQAFLLRTFEPDPRLRASAQELLGDPFLQPGKRSRSPGSPRHTPRPSGTPSSTSSPSADSATQSQTFPRPQAPSQHPPSPP KRCLSYGDTSQLRVPEESAAEEPASPEESSGLSLLHQESKRRAMLAAVLEQEVPILAENLLDQEQDSRLSRNHVELLLRCLGAQIHTPNRRQLAQELRALQAQLRAQSLSPALLKGPLFAFPDAVKQI LRRRQIRPHWMFVLDSLLSRAVRAALAVLDAEAEKKAVSPKSEEWSQGESQQKPLESQPPLQSQLPPEQEPPSLMIQLGLLRAETDRLRDILAEKERECQALVQQALHRVHAETRTYALASETPATLP KDQKLVQWLQDLSVDPTTIQTLLSHSFTLQTLLTCATQDDLVYTRIRYILGPPAVNHVAPASNMRASPALWACLDSSLKTTGEQVLLGIAVPNERAGAAFWLNYIDP
hide sequence
RefSeq Acc Id:
XP_006239082 ⟸ XM_006239020
- Peptide Label:
isoform X2
- Sequence:
MAGPCPGAGVLERAGSCWQDPLAEALSRGRSSPAVAGRGCARSRPLSVVYVLTREPGPGVEPGSGTEAEPLPLRCLREACAQLQSTRPPPQLRSLPFATLALGDTAALDSFYNADVVVLEVSNSLAQP SLFYHLGVRESFSMTNNVLLCSQAELPDLQALRDCVGSYTLIPYVVTATGRVLCGDAGLLRGIADGLVQAGVGTEALLTPLVGRLVRLLEATPTDSCGYFRETIRQDIRKARERFSGQQLRQELARLQ RRLDSVELLSPDIIMNLLLSYRDVQDYSAIIELVETLQALPTCDVAEQHNVCFHYTFALNRRNRPGDREKALAVLLPLVKHEGPVAPDLYCMCGRIYKDMFFSSSFQSTGHLEQAYHWYRKAFDVEPS LHSGINAAVLLIAAGKHFDDSEELQLIGMKLGCLLARKGCVEKMQYYWDVGFYLGAQILANDPIQVVLAAEQLYKLNAPIWYLVSVMETFLLYQHFRPTPEPSGGPVLRAHFWLHFLLQSCQPFKATP PQEDQCLVLVLEINKVLLPARLEIQGADPMSAVTLSLLEPETQDDPSSWTFPVTSICGISASKLDQRCCFLYALPPAQDVQLCFPSVERCRWFCSQIQVLVMNPDSSAPTEEAEGTREVLEFDYEYSE TGERLVLGKGTYGVVYAGRDRHTRVRIAIKEIPERDSRFSQPLHEEIALHKRLRHKNIVRYLGSASQGGYLKIFMEEVPGGSLSSLLRSVWGPLKDNESTISFYTRQILQGLSYLHENRIVHRDIKGD NVLINTFSGLLKISDFGTSKRLAGITPCTETFTGTLQYMAPEIIDQGPRGYGKAADIWSLGCTVIEMATGWPPFHELGSPQAAMFQVGMYKVHPPVPSSLSAEAQAFLLRTFEPDPRLRASAQELLGD PFLQPGKRSRSPGSPRHTPRPSGTPSSTSSPSADSATQSQTFPRPQAPSQHPPSPPKRCLSYGDTSQLRVPEESAAEEPASPEESSGLSLLHQESKRRAMLAAVLEQEVPILAENLLDQEQDSRLSRN HVELLLRCLGAQIHTPNRRQLAQELRALQAQLRAQSLSPALLKGPLFAFPDAVKQILRRRQIRPHWMFVLDSLLSRAVRAALAVLDAEAEKKAVSPKSEEWSQGESQQKPLESQPPLQSQLPPEQEPP SLMIQLGLLRAETDRLRDILAEKERECQALVQQALHRVHAETRTYALASETPATLPKDQKLVQWLQDLSVDPTTIQTLLSHSFTLQTLLTCATQDDLVYTRIRYILGPPAVNHVAPASNMRASPALWA CLDSSLKTTGEQVLLGIAVPNERAGAAFWLNYIDP
hide sequence
RefSeq Acc Id:
XP_006239084 ⟸ XM_006239022
- Peptide Label:
isoform X4
- Sequence:
MCSSVPRQSSLTCRPFVRMFSRRTRGYFRETIRQDIRKARERFSGQQLRQELARLQRRLDSVEL LSPDIIMNLLLSYRDVQDYSAIIELVETLQALPTCDVAEQHNVCFHYTFALNRRNRPGDREKALAVLLPLVKHEGPVAPDLYCMCGRIYKDMFFSSSFQSTGHLEQAYHWYRKAFDVEPSLHSGINAA VLLIAAGKHFDDSEELQLIGMKLGCLLARKGCVEKMQYYWDVGFYLGAQILANDPIQVVLAAEQLYKLNAPIWYLVSVMETFLLYQHFRPTPEPSGGPVLRAHFWLHFLLQSCQPFKATPPQEDQCLV LVLEINKVLLPARLEIQGADPMSAVTLSLLEPETQDDPSSWTFPVTSICGISASKLDQRCCFLYALPPAQDVQLCFPSVERCRWFCSQIQVLVMNPDSSAPTEEAEGTREVLEFDYEYSETGERLVLG KGTYGVVYAGRDRHTRVRIAIKEIPERDSRFSQPLHEEIALHKRLRHKNIVRYLGSASQGGYLKIFMEEVPGGSLSSLLRSVWGPLKDNESTISFYTRQILQGLSYLHENRIVHRDIKGDNVLINTFS GLLKISDFGTSKRLAGITPCTETFTGTLQYMAPEIIDQGPRGYGKAADIWSLGCTVIEMATGWPPFHELGSPQAAMFQVGMYKVHPPVPSSLSAEAQAFLLRTFEPDPRLRASAQELLGDPFLQPGKR SRSPGSPRHTPRPSGTPSSTSSPSADSATQSQTFPRPQAPSQHPPSPPKRCLSYGDTSQLRVPEESAAEEPASPEESSGLSLLHQESKRRAMLAAVLEQEVPILAENLLDQEQDSRLSRNHVELLLRC LGAQIHTPNRRQLAQELRALQAQLRAQSLSPALLKGPLFAFPDAVKQILRRRQIRPHWMFVLDSLLSRAVRAALAVLDAEAEKKAVSPKSEEWSQGESQQKPLESQPPLQSQLPPEQEPPSLMIQLGL LRAETDRLRDILAEKERECQALVQQALHRVHAETRTYALASETPATLPKDQKLVQWLQDLSVDPTTIQTLLSHSFTLQTLLTCATQDDLVYTRIRYILGPPAVNHVAPASNMRASPALWACLDSSLKT TGEQVLLGIAVPNERAGAAFWLNYIDP
hide sequence
RefSeq Acc Id:
XP_008762359 ⟸ XM_008764137
- Peptide Label:
isoform X3
- UniProtKB:
A0A8I5ZR53 (UniProtKB/TrEMBL)
- Sequence:
MAGPCPGAGVLERAGSCWQDPLAEALSRGRSSPAVAGRGCARSRPLSVVYVLTREPGPGVEPGS GTEAEPLPLRCLREACAQLQSTRPPPQLRSLPFATLALGDTAALDSFYNADVVVLEVSNSLAQPSLFYHLGVRESFSMTNNVLLCSQAELPDLQALRDCVGSYTLIPYVVTATGRVLCGDAGLLRGIA DGLVQAGVGTEALLTPLVGRLVRLLEATPTDSCGYFRETIRQDIRKARERFSGQQLRQELARLQRRLDSVELLSPDIIMNLLLSYRDVQDYSAIIELVETLQALPTCDVAEQHNVCFHYTFALNRRNR PGDREKALAVLLPLVKHEGPVAPDLYCMCGRIYKDMFFSSSFQSTGHLEQAYHWYRKAFDVEPSLHSGINAAVLLIAAGKHFDDSEELQLIGMKLGCLLARKGCVEKMQYYWDVGFYLGAQILANDPI QVVLAAEQLYKLNAPIWYLVSVMETFLLYQHFRPTPEPSGGPVLRAHFWLHFLLQSCQPFKATPPQEDQCLVLVLEINKVLLPARLEIQGADPMSAVTLSLLEPETQDDPSSWTFPVTSICGISASKL DQRCCFLYALPPAQDVQLCFPSVERCRWFCSQIQVLVMNPDSSAPTEEAEGTREVLEFDYEYSETGERLVLGKGTYGVVYAGRDRHTRVRIAIKEIPERDSRFSQPLHEEIALHKRLRHKNIVRYLGS ASQGGYLKIFMEEVPGGSLSSLLRSVWGPLKDNESTISFYTRQILQGLSYLHENRIVHRDIKGDNVLINTFSGLLKISDFGTSKRLAGITPCTETFTGTLQYMAPEIIDQGPRGYGKAADIWSLGCTV IEMATGWPPFHELGSPQAAMFQVGMYKVHPPVPSSLSAEAQAFLLRTFEPDPRLRASAQELLGDPFLQPGKRSRSPGSPRHTPRPSGTPSSTSSPSADSATQSQTFPRPQAPSQHPPSPPKRCLSYGD TSQLRVPEESAAEEPASPEESSGLSLLHQESKRRAMLAAVLEQEVPILAENLLDQEQDSRLSRNHVELLLRCLGAQIHTPNRRQLAQELRALQAQLRAQSLSPALLKGPLFAFPDAVKQILRRRQIRP HWMFVLDSLLSRAVRAALAVLDAEAEKKAVSPKSEEWSQGESQQKPLESQPPLQSQLPPEQEPPSLMIQLGLLRAETDRLRDILAEKERECQALVQQALHRVHAETRTYALASETPATLPKDQKLVQW LQDLSVDPTTIQTLLSHSFTLQTLLTCATQDDLVYTRIRGGMVCRIWRAILAQRAGATSVTPGPRDAE
hide sequence
Ensembl Acc Id:
ENSRNOP00000012463 ⟸ ENSRNOT00000012463
RefSeq Acc Id:
XP_038965707 ⟸ XM_039109779
- Peptide Label:
isoform X4
Ensembl Acc Id:
ENSRNOP00000080621 ⟸ ENSRNOT00000093926
RGD ID: 13694109
Promoter ID: EPDNEW_R4633
Type: multiple initiation site
Name: Map3k6_1
Description: mitogen-activated protein kinase kinase kinase 6
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 5 151,436,435 - 151,436,495 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-04-30
Map3k6
mitogen-activated protein kinase kinase kinase 6
Map3k6_predicted
mitogen-activated protein kinase kinase kinase 6 (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Map3k6_predicted
mitogen-activated protein kinase kinase kinase 6 (predicted)
Symbol and Name status set to approved
70820
APPROVED